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I  INTRODUCTION1 
Chemical analysis holds an important position in our modern society. Knowledge 
of analytical procedures has become essential in practically all arts and science as well as 
technical separation of industry. The discovery of new medicines, new fabrics, and new 
alloys would not be possible without the services of analytical chemist. Analytical 
chemistry is such an important part of our industrial structure and advancing science that 
without it our present day economy couldn’t exist. 
In early days of chemistry, analysis was most synonymous with chemistry itself. 
Robert Boyle (1626-1691) was first introduced the word “analysis” to apply to the 
identification of individual substance in presence of each other. Berzelius (1779-1848) 
developed many new experimental methods which include the separation of the metal 
constituents from a number of complex minerals. 
The last 50years have witnessed an expanding interest in the problems and 
methods of chemical analysis. There has been a vast increase in the number of analysis 
that is needed in daily problems of engineering metallurgy, manufacturing and many 
other fields. Agriculture has been aided with increased yields and enhanced soil fertility 
through accurate chemical analysis. Advances in medicine and public health would not 
be possible without chemical analysis.Eg-analysis of blood, urine. 
SCOPE OF QUANTITATIVE ANALYSIS 
Quantitative analysis is concerned with the identification and separation of 
chemical substances and chemical principles on which such procedures are based on. 
Quantitative analysis deals with the determination of the amount of a chemical substance 
represent either alone or in a simple or complex mixture of other substances. 
There are two types of quantitative analysis. 
Group 1:-Methods in which the final measurement of the substance sought is made by 
direct or indirect measurement of volume and weight after proper treatment of a 
measured portion of the material to be analysed.They are of 2 types. 
a) Gravimetric    
b) Titrimetric. 
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a) Gravimetric:- Analysis is carried out by a series of weighing operation . The most 
usual method is the isolation of a substance sought by direct precipitation of substance, or 
a suitable compound of it with subsequent purification. E.g. Detection of chlorides, 
sulphates in water soluble samples in the absence of interfering substances. 
b) Titrimetric:-In this the substances sought is determined by a careful measurement of 
volume of a solution of known concentration required to react with the solution to be 
analysed. They are of 2 types.  
1. Neutralization reaction. E.g.:-Determination of acids and bases 
2. Oxidation-reduction reaction. 
Group 2:-This involves methods in which the final measurement is made upon the system 
as a whole. Eg:-Measurement of specific gravity. 
• Thermal measurement-Melting point, Boiling point 
• Electrical measurement-Dielectric constant 
• Optical measurement 
ANALYTICAL CHEMISTRY2 
 Analytical chemistry deals with the solving of quantitative problems. In 
quantitative analysis the goal is to determine what are the constituents present in the 
sample while in qualitative analysis the goal is to determine how much of each 
constituent in sample. An important part of analytical chemist’s task is choosing the 
optimum pathway, a choice which is simplified only through the assimilation of 
knowledge and experience. Thus in solving analytical problems the analytical chemist is 
often required to design or repair electronic systems, design instruments, interpret spectra 
and instrumental data, perform chemical analysis with simple chemicals and solutions, 
develop and evaluate new procedures or modify old ones, separation of simple, complex 
mixtures, purify samples and write computer programmes. 
Historically chemistry could be easily divided into 5 areas.1.Analytical, 
2.Biochemical, 3.Inorganic, 4.Organic, 5.Physical. The importance of analytical 
chemistry in related scientific areas can be illustrated by considering its impact on 
clinical analysis, in pharmaceutical research, QC and in environmental analysis. 
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The measurement of properties such as absorption or emission of energy, optical 
rotation, refractive index, equilibrium constant is more complex. The reliability, utility, 
accuracy, interpretation and specificity of these measurements are the responsibilities of 
an analytical chemist. Another important responsibility of an analyst is to make the 
measure which is usually based on a tried and tested procedure in a routine manner. 
Analytical chemistry deals with the methods for determining the composition of 
samples or matter. A qualitative method yields information about the identity of atomic 
or molecular species or the functional groups in the sample. A quantitative method, in 
contrast, provides numerical information as to the relative amount of one or more of 
these components. 
 
TYPES OF ANALYSIS3 
1. Proximate analysis:-The amount of each element in a sample is determined with 
no concern as to the actual compounds present. 
2. Partial analysis:-This deals with the determination of selected constituents in the 
sample. 
3. Trace constituent analysis:-The determination of specified components present in 
very minute quantity. 
4. Complete analysis:-In this the proportion of each component of sample is 
determined. 
On the basis of sample size, analyses are classified into three. They are:- 
a. Macro methods;-Determination of quantities of 0.1gm or more. 
b. Semi micro methods:-Deals with quantities ranging from 0.01gm -0.1gm. 
c. Micro methods:-Quantities not exceeding 0.001 
[Major constituents-One present in excess of 1%, Minor constituents-Constituents 
from 0.01-1% of sample, Trace constituents-One present to an extent of less than 
0.01% of sample] 
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ANALYTICAL INSTRUMENTATION4 
Analytical instrumentation plays an important role in the production and 
valuation of new products and the protection of consumers and the  environment. Most 
analytical techniques fit into one of the three principal areas: spectroscopy, 
electrochemistry and chromatography. The first task is to define an analytical problem. 
The analyst should determine the nature of  sample, the end use of the analytical results, 
the species to be analyzed and the information required. Once the problem has been 
defined the next task is to select the appropriate method. 
Classification of analytical methods:-5 
 Various new analytical techniques which are being used can be  categorized as 
 follows:- 
 GENERAL CLASSIFICATION 
 SCIENTIFIC CLASSIFICATION 
 TRADITIONAL CLASSIFICATION 
 MODERN CLASSIFICATION 
GENERAL CLASSIFICATION:- 
 This classification includes:- 
a) Spectral methods: These are based on light absorption or emission characteristics 
of drugs. 
E.g.:-UV, Visible, NMR Spectroscopy, Fluorimetry, Colorimetric etc. 
b) Chromatographic methods: These are based on the affinity or partition coefficient 
differences between drugs. 
E.g.:-Thin layer chromatography (TLC), High Performance Liquid 
Chromatography (HPLC), Paper chromatography etc. 
c) Electro analytical method: These are based on the electrochemical property of the 
drug. 
E.g.:-Potentiometry, Conductometry, Polarography, Amperometry. 
d) Biological &microbiological methods: In these methods animals (or) 
microorganisms are used and the activity is determined. 
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E.g.:-Biological assay of some vitamins, microbiological assay of antibiotics 
&vitamins. 
e) Radioactive methods: In these methods the radioactivity is measured for 
analyzing the drugs. 
E.g.:-Radio Immune Assay (RIA) 
f) Physical methods: In these methods some physical characteristics of drugs are 
measured. 
E.g.:-Differential Thermal Analysis (DTA), Differential Scanning Calorimetry 
(DSC). 
g) Miscellaneous technique methods: Conventional titrimetric methods,polarimetric 
methods etc. 
SCIENTIFIC CLASSIFICATION:- 
 This classification includes:- 
a) Instrumental methods: A physical property of a substance is measured to 
determine its chemical composition. 
E.g.:-Electro-chemical method- change in the electrical properties of the system. 
Electrogravimetry, Potentiometry, Conductometry etc. 
b) Chemical methods: In these methods chemical reaction or chemical extraction is 
involved. These are volumetric and gravimetric method. 
TRADITIONAL CLASSIFICATION:- 
 This classification includes:- 
a) Gravimetric method: This method involves measurement of weight. The 
substance to be determined is converted into an insoluble precipitate which is 
collected and weighed or in electro gravimetry, electrolysis is carried out and the 
material deposited on one of the electrodes is weighed. It may be carried out by:- 
• Precipitation 
• Electrode position 
• Volatilization 
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b) Volumetric method: These are the methods in which measurements are made in 
volume. In this technique volume of titrant is measured and these are of four 
types depending on the type of reaction involved in it. 
• Acid-base titration 
• Oxidation-reduction titration 
• Precipitation titration 
• Complexometric titration 
c) Optical method: These methods are based on how the sample acts towards 
electromagnetic radiation. 
• Absorption or emission of radiant energy 
• Bending of radiant energy 
• Scattering of radiant energy 
d) Electrical method: It involves the detection of amount of concentration of a 
component in terms of 
• Component upon an electrode 
• Upon an impressed voltage 
• Sample in changing the chemical state of component 
e) Separation method: Based on the principle of affinity of the component to be 
separated (or) analyzed. 
MODEREN CLASSIFICATION:- 
This classification includes the modern & latest methods of analysis. 
a) Chemical methods: 
i. Acidimetric and alkalimetric methods 
ii. Non-aqueous titration methods 
iii. Oxidation-reduction methods 
iv. Argentrimetric methods 
v. Complexometric methods 
vi. Gravimetric methods 
vii. Miscellaneous types of methods 
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b) Physical methods: 
i. Refractometry 
ii. Polarimetry 
iii. Optical rotatory dispersion 
c) Electrochemical methods: 
i. Electro analytical methods 
ii. Polarography 
d) Spectroscopic methods: 
i. Visible spectrophotometry 
ii. Ultraviolet spectrophotometry 
iii. Flame and atomic absorption spectrophotometry 
iv. Fluorimetry 
v. Infrared spectrophotometry 
vi. Nuclear magnetic resonance spectrophotometry 
vii. Mass spectrophotometry 
e) Separation methods: 
i. Chromatographic methods 
ii. Electrophoresis 
f) Radiochemical methods 
g) Miscellaneous types: 
i. Particle size analysis 
ii. Differential Scanning Calorimetry (DSC) 
 iii Differential Thermal Analysis (DTA) 
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CHROMATOGRAPHY 
                            According to USP51 chromatography can be defined as a procedure by 
which solutes are separated by a differential migration process in a system consisting of 
two or more mobile phases, one of which the individual substance exhibit different 
mobilities by reason of difference in adsorption, partition, solubility, vapour phase, 
molecular size or ionic charge density. 
                             Chromatography52 is a new separation technique, discovered by 
Dr.Michael Tswett (1906) for the separation of complex mixtures by the process of 
adsorption. According to him chromatography is defined as a process used in separating 
substance by filtering the solution through a column of finely powdered adsorbent and 
then developing the column with a solvent. 
 
Classification of chromatographic methods 
¾ In all chromatographic techniques53,  difference in affinity involves the process of 
either adsorption or partition. In adsorption, the binding of a compound, to the 
surface of solid phase takes place where as in partition the relative solubility of a 
compound in two phases, results in partition of compound between two phases. 
¾ Components of a mixture are carried through the stationary phase by the flow of a 
mobile phase and the separation is based on difference in migration rates among 
the mobile phase components. 
¾ Elution: - It is a process in which solutes are washed through a stationary phase 
by the movement of a mobile phase. The mobile phase that exits the column is 
termed as eluate. 
¾ Chromatogram: - If a detector that responds to solute concentration is placed at 
the end of the column during elution and its signal is plotted as a function of time, 
a series of peaks are obtained called chromatogram. 
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Chromatography 
 
 
 
Adsorption                                                                     Partition 
 
 
Gas-solid             Liquid-liquid                                Gas liquid                    Liquid-liquid 
 
 
Adsorption column                    Thin layer  
Chromatography                   Chromatography 
  (ACC)                                  (TLC) 
 
 
 
Partition column               Paper                Thin layer                 Reverse phase 
Chromatography         Chromatography     Chromatography         partition(extraction) 
  (PCC)                              (PC)                       (TL C)                     Chromatography 
(RPPC) 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                        INTRODUCTION 
 
Department of Pharmaceutical Chemistry  Page 10 
 
High Performance Liquid Chromatography (HPLC) 54 
            The technique of HPLC was discovered by Csaba Horvath (1964), Kirkland & 
Huber (1969). The first mixture to be separated was nucleic acid components associated 
with thyroid function. 
            All forms of LC are differential migration processes where sample components 
are selectively retained by a stationary phase. The different techniques are LSC 
(adsorption chromatography), LL (Partition chromatography). LLC is divided, based on 
relative polarities of stationary phase and mobile phase i.e. Reverse Phase 
chromatography and Ion Pair chromatography. In addition to LSC and LLC. LC 
comprises bonded phase chromatography, gel permeation chromatography, ion exchange 
& affinity chromatography. 
         In HPLC, eluents from the solvent reservoir is filtered, pressurized and pumped 
through the column. A mixture of solutes injected at the top of the column is separated 
into components. Individual solutes are monitored by the detector and recorded 
automatically. 
The principal advantages of HPLC compared to classical column chromatography are:- 
 Improved resolution of separated substances. 
 Faster separation time. 
 Increased accuracy, precision, sensitivity. 
 
Types of chromatographic techniques55 
I. Based on modes of chromatography 
 Normal phase- Stationary phase is polar 
                                  Mobile phase is non-polar 
 Reverse phase- Stationary phase is non polar 
                                  Mobile phase is polar 
II. Based on principle of separation 
 Adsorption (Liquid chromatography) - Analyte species are adsorbed into the   
surface of a polar packing. 
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 Partition (Liquid-liquid chromatography) –Based upon the difference in 
partition coefficient of the individual components of a mixture between a 
liquid stationary phase and a gaseous or liquid mobile phase. 
 Ion-exchange (Ion pair chromatography)  
 Size exclusion (Gel permeation/gel filtration) – In this the fractionation is 
based on molecular weight. 
 Affinity – In this a covalent bonding between the reagents called “affinity 
ligand” and solid supports takes place. 
 Chiral phase- In this a “Chiral resolving agent or Chiral stationary phase” 
preferentially complexes one of the enantiomers. 
III. Based on elution technique 
 Isocratic- In this the composition of solvent remains constant. 
 Gradient -In this the composition is changed continuously or in a series of  
steps. 
IV. Based on scale of operation 
 Analytical HPLC 
 Preparative HPLC 
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II   DRUG PROFILE6 
INTRODUCTION 
   Nitazoxanide49 was originally discovered in the 1980s by Jean- François 
Rossignol at the Pasteur Institute. Initial studies demonstrated activity versus 
tapeworms. In vitro studies demonstrated much broader activity. Dr. Rossignol co-
founded Romark Laboratories, with the goal of bringing nitazoxanide to market as an 
anti-parasitic drug. Initial studies in the USA were conducted in collaboration with 
Unimed Pharmaceuticals, and focused on development of the drug for treatment of 
cryptosporidiosisin AIDS. Controlled trials began shortly after the advent of effective 
anti-retroviral therapies.  
Romark launched an impressive series of controlled trials. No other agent has 
proven efficacy in the treatment of cryptosporidiosis. However, a placebo-controlled 
study of nitazoxanide in cryptosporidiosis demonstrated significant clinical 
improvement in adults and children with mild illness. Among malnourished children 
in Zambia with chronic cryptosporidiosis, a three-day course of therapy not only led 
to clinical and parasitological improvement, but also improved survival.  In treatment 
of giardiasis, nitazoxanide was superior to placebo and comparable to metronidazole. 
Nitazoxanide was successful in the treatment of metronidazole-resistant giardiasis. 
Studies have suggested efficacy in the treatment of cyclosporiasis, isosporiasisand 
ameobiasis. 
DESCRIPTION7 
 Nitazoxanide is a synthetic nitro thiazolyl-salicylamide derivative approved 
for the treatment of infectious diarrhoea caused by Cryptosporidium parvum and 
Giardia lamblia. Following oral administration it is rapidly hydrolyzed to its active 
metabolite, tizoxanide, which is observed 1-4 hours after administration. It is excreted 
in the urine, bile and faeces. 
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CATEGORY 
                Anti parasitic agents 
PROPERTIES 
 
1 
 
Physical state 
 
 Solid, white or yellowish, crystalline powder 
 
2 
 
Melting point 
 
202 0C 
 
3 
 
Experimental properties 
                Property           Value 
                 log P                    1.2 
 
4 
 
Predicted properties 
 
 Water solubility 
 
 7.55e-03g/l 
                    log P              2.14 
                  Log S             -4.61 
Hydrogen acceptor count             5 
Hydrogen donor count              1 
 
 
 
 
 
 
 
 
 
 
Polar surface area           114.11 
Rotatable bond count             5 
Refractivity          73.89 
Polarizability 27.54 
 
5 
 
Solubility 
Soluble in N, N-dimethyl acetamide; very slightly soluble 
in alcohol; practically insoluble in water. 
   
PHARMACOLOGY13 
Mechanism of action: The antiprotozoal activity of nitazoxanide is believed to be 
due to interference with the pyrvate: ferredoxinoxido reductase (PFOR) enzyme-
dependent electron transfer reaction which is essential for anaerobic energy 
metabolism. Studies have shown that PFOR enzyme from Giardia lamblia directly 
reduces nitazoxanide by transfer of electrons in the absence of  ferredoxin. The DNA 
–derived PFOR protein sequence of Cryptosporidium parvum appears to be similar to 
that of the Giardia lamblia. Interference with the PFOR enzyme-dependent electron 
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transfer reaction may not be the only pathway by which nitazoxanide exhibits 
antiprotozoal activity. 
 
 Pharmacokinetics14: 
1. Absorption: The relative bioavailability of the suspension compared to the 
tablet was 70%. 
2. Volume of distribution: Not available. 
3. Metabolism: Rapidly hydrolyzed to an active metabolite, tizoxanide 
(desacetyl-nitazoxanide) 
4. Excretion: Tizoxanide is excreted in urine 
Protein binding: Very high (greater than 99%), bound to proteins. Binding is not 
affected by degree of renal impairment. 
Clearance: Not available. 
Half life: 3.5 hours in patients with normal renal function. 
 
Toxicity: In acute studies in rodents and dogs, the oral LD50 was higher than 
10,000mg/kg. Single oral dose administered to healthy adult volunteers without 
significant adverse effects. 
 
Storage and stability: 15Store the tablets, unsuspended powder, and the reconstituted 
oral suspension at 250C (77 0F) 
 
Precautions: 
i. General: Nitazoxanide must be administered with caution to patients with 
hepatic and biliary disease, to patients with renal disease and to patients with 
combined renal and hepatic disease. 
ii. Information for patients: Alinia tablets and Alinia suspension should be taken 
with food. Diabetic patients and caregivers should be aware that the oral 
suspension contains 1.48gm of sucrose per ml. 
iii. Carcinogenicity, mutagenicity, impairment of fertility, no direct effect 
reported. 
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iv. Pregnancy: Teratogenic effect. 
v. Nursing mothers: Caution must be exercised during administration. 
 
ADVERSE DRUG REACTIONS:- 
Alinia tablets:-: 
9 Body as a whole-asthenia, fever, pain, allergic reaction, pelvic pain, back 
pain, chills. 
9 Nervous system- dizziness, somnolence, insomnia, tremor, hypesthesia. 
9 Digestive system-vomiting, dyspepsia, anorexia, flatulence, constipation, 
dry mouth, thirsts. 
9 Urogenital system-discoloured urine, dysuria, kidney pain 
9 Metabolic and nutrition-increased SGPT 
9 Hemic and Lymphatic system- Anemia, leukocytosis. 
9 Skin- rash, pruritis. 
9 Respiratory system- epitaxis, pharyngitis. 
9 Cardiovascular system- tachycardia, hypertension. 
9 Muscular system-myalgia, leg cramps. 
Alinia oral suspension:- 
9 Digestive system-nausea, anorexia, flatulence 
9 Body as whole- fever, infection, malaise. 
9 Metabolic and nutrition-increased creatinine, increased SGPT 
9 Skin-pruritis, sweat 
9 Respiratory system-rhinitis 
9 Nervous system-dizziness 
9 Urogenital system-discolored urine 
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DRUG INTERACTION:- 
Since it is highly bound to plasma proteins, caution should be taken while 
administering nitazoxanide with other highly plasma-bound drugs with narrow 
therapeutic indices. It is expected that no interaction would occur when nitazoxanide 
is co-administered with drugs that either metabolized or inhibited by cytochrome  
P450enzyme. 
 
INDICATIONS: - 16 
1.  Antiprotozoal agent 
(1)   The first-line choice for the treatment of illness caused by Cryptosporidium 
parvum or Giardia lamblia infection in immunocompetent adults and children, 
and is an option to be considered in the treatment of illness caused by other 
protozoa and/or helminthes. 
(2)  Treatment of infectious diarrhea caused by Cryptosporidium parvum and 
Giardia lamblia in pediatric patients 1 year through 11 years of age, which 
has  been approved by FDA, USA 
(3)   Metronidazole-resistant giardiasis. 
  
2.  Anti-virus 
(1)   Phase II clinical trials for the treatment of hepatitis C, in combination with 
pig interferon α - 2α and ribavirin. 
(2)   Chronic hepatitis B 
(3)   Reduced the duration of rotavirus disease in hospitalized pediatric patients. 
(4)   Activity against influenza A virus 
  
1. Treatment of equine protozoal myeloencephalitis (EPM) caused by 
sarcocystisneurona in horse 
2.  Grass and flowers in western countries. 
 
CONTRAINDICATIONS: - 17 
Alinia tablets and Alinia suspensions are contraindicated in patients with a prior 
hypersensitivity to nitazoxanide or any other ingredients in the formulations. 
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DOSAGE&ADMINISTRATION:- 
Indication Age Dosage Duration
Treatment of diarrhea 
caused by Giardia lamblia or 
Cryptosporidium parvum 
 
1-3 years 
 
 
 
4-11years 
5ml of alinia for oral suspension 
(100mg NTZ) every 12hrs with 
food. 
 
 
10ml of alinia for oralsuspension 
(200mg NTZ) every 12hrs with 
food. 
 
 
 
 
 
 
      3days 
 
 
 
 
 ≥12years 1Alinia tablet (500mg NTZ) every 
123hrs with food or 25ml of 
Aliniaoral suspension (500mg 
NTZ) every 12hrs with food. 
 
OVERDOSAGE:- 
In the event of over dosage, gastric lavage may be given soon after oral 
administration. Patients should be carefully observed and given symptomatic and 
supportive treatment. 
 
DOSAGE FORMS:- 
• Oral suspension 
• Tablet 
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Singh H.P, et al; developed the simultaneous determination of nitazoxanide & 
ofloxacin using three simple, rapid, economical, accurate & reproducible 
spectrophotometric methods, namely vierodt’s method, Q-analysis, dual 
wavelength method. 1st method, is based on formation and solving of 
simultaneous equation at 346.361nm (nitazoxanide) and 296.496nm (ofloxacin). 
Second method  is based on absorbance ratio at two selected wavelength 
307.520nm & 346.361nm. In third method two wavelengths were selected for 
each drug in a way so that the difference in absorbance were measured for the 
determination of ofloxacin, similarly difference in absorbance at 302.4nm and 
289.2nm were measured for determination of nitazoxanide. The results of 
analysis were validated statistically. Recovery studies gave satisfactory results 
indicating that none of common additives & recipients interfere the assay 
method. 
 
3. Colorimetric estimation of Nitazoxanide and Ofloxacin in Pharmaceutical 
dosage form.20 
Vidya Sagar, et al; developed the simultaneous estimation of nitazoxanide & 
ofloxacin in tablet dosage form i.e. they launched a combined therapy of both 
drugs. The colorimetric estimation where the wavelengths selectedfor 
quantitation was486nm (ofloxacin) and 747nm (nitazoxanide). The method obeys 
Beer’s law in concentration range from 5-50mcg/ml of OFL and 10-100mcg/ml 
for NTZ. The percentage label claim and percentage label claim and percentage 
recoveries estimated were close to 99.55% and 98.75% with low value of 
standard deviation. 
 
4. Development of a simple, rapid and validated spectrophotometric method for 
nitazoxanide in pharmaceutical formulations and compressed with HPLC21. 
Marcelo Donald Malesuik, et al; developed a rapid, economical, reproducible and 
a simple direct spectrophotometric method was developed for the assay of 
nitazoxanide in pharmaceutical formulations. Nitazoxanide concentration was 
estimated in water at 345 nm and pH 4.5. The method was suitable and validated 
for specificity, linearity, precision, and accuracy. There was no interference of the 
excipients in the determination of the active pharmaceutical ingredient. The 
proposed method was successfully applied in the determination of nitazoxanide 
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in coated tablets and in powders for oral suspension. This method was compared 
to a previously developed and validated method for liquid chromatography to the 
same drug. There was no significant difference between these methods for 
nitazoxanide quantitation. 
 
5. Estimation of Nitazoxanide by U.V Spectrophotometric method22. 
Vanitha J.A, et al; developed an accurate, precise, specific, linear, rapid and cost 
effective spectroscopic methods in UV region for the determination of 
nitazoxanide in bulk and tablet dosage forms. Nitazoxanide is a new anti-
protozoal drug, which showed maximum absorbance at 346nm with apparent 
molar absorptivity of 23783.92 Lmol-1cm-1. Beers law obeyed in the 
concentration range of 2-14μg/ml. According to ICH guidelines, results of the 
analysis were validated statistically and by recovery studies. 
 
6. Simultaneous UV Spectrophotometric Method for the Estimation of 
Nitazoxanide and Ofloxacin in Combined Dosage Form23. 
Senthilraja M, developed a simple, sensitive, rapid, accurate and precise 
simultaneous UV-spectrophotometric method for the estimation of nitazoxanide 
and ofloxacin dosage form. Ratio of absorbance at two selected wavelengths, one 
of which an isoabsorbance point and being the λ max of the one of the two 
components. Ofloxacin has absorbance maxima at 300nm and nitazoxanide has 
absorbance maxima at 344nm in Ethanol. The isoabsorbance point of ofloxacin 
and nitazoxanide was found to be 347nm. Linearity was obtained in the 
concentration range of 2-25μg/ml for each nitazoxanide and ofloxacin. Results of 
analysis have been validated statically and by recovery studies. 
 
7. Simultaneous determination of nitazoxanide and ofloxacin in tablet by 
ultraviolet spectrophotometry (dual wavelength method) 24. 
Shailendra Bindaiya, et al; devoloped a simple, accurate, and precise dual 
wavelength spectrophotometric method for the simultaneous determination of 
nitazoxanide and ofloxacin in combined pharmaceutical dosage forms. The 
principle for dual wavelength method is “the absorbance difference between two 
points on the mixture spectra is directly proportional to the concentration of the 
component of interest”. The wavelengths selected for determination of 
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nitazoxanide were 271.5nm & 359.5nm, whereas, the wavelengths selected for 
determination of ofloxacin were 300.5nm and 365.5nm. A mixture of 
dichloromethane and n-Hexane (60:40) was taken as a solvent. Regression 
analysis of beers plots showed good correlation in the concentration range of 5-
25μg/ml for nitazoxanide and 2-10 μg/ml for ofloxacin. Accuracy of method was 
found between 98.5-101.5%. The precision (intra-day, inter-day and analyst to 
analyst) of method was found within limits (%CV<2). The proposed method was 
successfully applied to determination of these drugs in laboratory-prepared 
mixtures and commercial tablets. 
 
8. Development and Validation of Spectrophotometric and Colorimetric Method 
for the determination of Nitazoxanide in its Bulk and Pharmaceutical Dosage 
Form(Tablets)25 
Lopamudra Adhikari, et al; developed two simple and sensitive spectroscopic 
methods in UV region and visible region for the estimation of Nitazoxanide in its 
pharmaceutical dosage forms. Method A is based on Nitazoxanide showing its 
absorption maxima at 238.3nm in acetonitrile and water (9:1). The method B is 
based on the reaction of Nitazoxanide with 1ml, 1% ferric chloride and 2ml, 
0.1%MBTH to produce a greenish color, characteristic light absorption at 732nm. 
These method obey Beer- Lambart’s  law at a concentration range of 5-40mcg/ml 
and 50-250mcg/ml respectively. The % recoveries were found out to be 98.75 – 
100.45. The results obtained with the proposed methods are in good agreement 
with the labeled amounts when tablet dosage forms were analyzed. 
 
9. Simultaneous High-Performance Liquid Chromatographic Determination of 
Nitazoxanide and Ofloxacin in Tablet Formulation 
Vipul P. Ranea, et al; developed a simple, rapid, and precise method for the 
quantitative simultaneous determination of nitazoxanide and ofloxacin in new 
tablet formulation. Chromatographic separation of the two drugs were achieved 
on an Ymc pack-AM C18, 25-cm analytical column using mobile phase 
consisting of 10 mmol L-1 dipotassium hydrogen phosphate: acetonitrile (65:35, 
v/v) finally the pH of the mobile phase was adjusted to 7.0 using o- phosphoric 
acid. The instrumental settings are flow rate of 1 mL min-1, column temperature 
at 300C, and detector wavelength of 254 nm. The internal standard method was 
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used for the quantification. Caffeine was used as an internal standard. The 
method validated for linearity, accuracy, precision, limit of detection, limit of 
quantification and robustness. The calibration curve shows excellent linearity 
over the concentration ranges of ofloxacin and nitazoxanide in the range of 20-
200μg mL-1 and 8-80 μg mL-1, respectively. The separation was completed less 
than 6 minutes. The proposed method can be used for the quality control of 
formulation products. 
 
10. Simultaneous RP-HPLC Estimation of Nitazoxanide and Ofloxacin in Tablet 
DosageForms27. 
 Siva Kumar R, et al; developed a Reverse Phase HPLC method for the 
determination of nitazoxanide and ofloxacin in bulk and tablet formulations. The 
determination was carried out by using Phenomenex C18 column with 0.24% 
sodium lauryl sulphate: acetonitrile: acetic acid(pH-4.0) (58:40:02) as the mobile 
phase. The flow rate was 1.5 ml/ min. and the eluents were monitored at 295 nm. 
The Retention time of nitazoxanide and ofloxacin were 2.2 and 5.4 respectively. 
Linearity for the nitazoxanide and ofloxacin were found in the range of 400-600 
μg/ml and 160 - 240 μg/ml respectively. The method was reproducible, with good 
resolution between nitazoxanide and ofloxacin and can be use for routine 
analysis. 
 
 
11. A Validated RP-HPLC Method for Simultaneous Estimation of Nitazoxanide 
and Ofloxacin in Pharmaceutical Formulation28. 
Premanand D.C,  et al; devoloped a validated reverse phase high performance 
liquid chromatography method for the simultaneous determination of 
Nitazoxanide and Ofloxacin in combined dosage form. Chromatography was 
carried out on a Cosmosil 5 C18 (4.6 mm × 250 mm, 5 μm) using Acetonitrile: 
0.005 M triethylamine Buffer in the ratio of 55:45 (v/v) as the mobile phase at a 
flow rate of 1.0 mL/min and eluents were monitored at 240 nm. The calibration 
curves were linear over the range of 160-240 μg/mL for Nitazoxanide and 400-
600 μg/mL for Ofloxacin. The average retention time of Dexrabeprazole and 
Domperidone were found to be 6.051 min and2.106 min respectively. The results 
of the analysis have been validated statistically and by recovery studies. 
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12. RP-HPLC method for simultaneous estimation of nitazoxanide and ofloxacin 
in tablets.29 
Sharma S, et al; developed a reverse phase high performance liquid 
chromatography method and for the simultaneous estimation of nitazoxanide and 
ofloxacin in tablet formulation. The separation and quantification was achieved 
by HiqSil C18 V Size 4.6mm  250mm column in isocratic mode, with mobile 
phase consisting of  acetonitrile-methanol 0.4mm citric acid, (60:30:10,v/v/v). 
Citric acid is used to mobilize nitazoxanide and ofloxacin in mobile phase. The 
mobile phase was pumped at a rate of 0.6ml/mt and the detection was carried out 
at 304nm. The retention time of nitazoxanideand ofloxacin was found to be 3.122 
and 5.902min, respectively. The method was validated for linearity,accuracy and 
precision. Linearity for ofloxacin and nitazoxanide were in range 2-36µg/ml and 
5-90µg/ml, respectively. The developed method was found to be accurate, precise 
and selective for simultaneous estimation of ofloxacin and nitazoxanide in 
tablets. 
 
13. Rapid determination of nitazoxanide in tablets using reversed-phase ultra-
performance liquid chromatography (UPLC) and high-performance liquid 
chromatography30.                   
Sakamoto T, et al; developed a simple and rapid determination method for 
nitazoxanide (NTZ), using reverse-phase HPLC and Ultra Performance Liquid 
Chromatography (UPLC). Only six minutes gradient condition for NTZ analysis 
using UPLC was achieved. The mobile phase consisted of a mixture of phosphate 
buffer (pH 6.0) and acetonitrile. The repeatability (relative standard deviation 
(RSD), n = 6) and the correlation coefficient from linearity (the range from 80% 
to 120% of amount) were 0.25% and 0.9963 for UPLC and 0.15% and 0.9988 for 
HPLC, respectively. The quantitative values of NTZ in tablets were 103.2% for 
HPLC and 98.7% for UPLC. The RSDs of quantitative values of sample solution 
were calculated to be 4.06% to 4.64% for HPLC and 0.15% to 0.36% for UPLC. 
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14. Simultaneous RPHPLC determination of nitazoxanide and ofloxacin in 
combined tablet dosage form. (Short Communication)(reverse phase high 
performance liquid chromatography)(Clinical report) 31. 
Kalta R, et al; devoloped a simple, precise, accurate, rapid and reproducible 
reverse phase high performance liquid chromatographic procedure for 
simultaneous determination of nitazoxanide and ofloxacin in tablet dosage form 
at a single wavelength. The mobile phase used was a combination of acetonitrile: 
0.25M potassium dihydrogen phosphate buffer (80:20) with 0.5%v/v of 
triethylamine and the pH was adjusted to 2.5 by adding orthophosphoric acid. 
The detection of the combined dosage form was carried out at 320 nm and flow 
rate was set to 1ml/min. Linearity was obtained in the concentration range of 5 to 
25 mg/ml of nitazoxanide and ofloxacin with correlation coefficients of 0.9987 
and 0.9995, respectively. The results of the analysis were validated statistically 
and recovery studies confirmed the accuracy of the proposed method. 
 
15. Development and validation of spectrophotometric methods for the estimation 
of nitazoxanide in tablet dosage form32. 
Lakshminarayana K.V, et al; developed two simple and sensitive visible 
spectrophotometric methods (A and B) for the quantitative estimation of 
nitazoxanide, in bulk drug and pharmaceutical dosage forms. Methods were 
based on the formation of reddish yellow coloured and green 
colouredchromogens, which were measured at 544 nm and 715 nm, respectively. 
The results obtained with the proposed methods are in good agreement with the 
labeled amounts when tablet dosage forms were analyzed. 
 
16. A validated stability indicating HPTLC method for the determination of 
nitazoxanide33.  
Gopu C.L, et al; developed and validated a simple, precise, selective and stability 
indicating HPTLC method for the determination of nitazoxanide in bilk drug and 
its formulations. Method employed TLC aluminium plates precoated with silica 
gel 60F 254 as the stationary phase. Solvent system consisted of ethyl acetate-
toluene methanol (4:6:1v/v/v). Nitazoxanide was subjected to hydrolysis, 
oxidation, photolysis and thermal decomposition to establish a validated stability 
indicating HPTLC method. Extensive degradation occurred in alkaline medium 
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and in oxidative stress condition and degradation product was well separated 
from pure drug. Densitometric analysis of nitazoxanide was carried out in 
absorbance mode at 350nm. Linear regression analysis data for mean calibration 
plots showed good linear relationship with r²=0.9997 in 400-1600ng/spot. 
Method was validated with respect to linearity, precision, accuracy, specificity, 
robustness. The limits of detection and quantization were 15 and 50ng/spot, 
respectively. HPTLC method could effectively separate drug from its degradation 
product and can be employed as a stability-indicating method. 
17. Development of a Validated Stability-Indicating LC Method for Nitazoxanide 
in Pharmaceutical Formulations34 
 
Marcelo Donadel Malesuik, et al; devoloped a reversed-phase liquid 
chromatographic (LC) method was developed for the assay of nitazoxanide 
(NTZ) in solid dosage formulations. An isocratic LC separation was performed 
on a Phenomenex Synergi Fusion C18 column (250 mm 4.6 mm, i.d., 4 lm 
particle size) using a mobile phase of 0.1% o-phosphoric acid solution, pH 6.0: 
acetonitrile (45:55, v/v) at a flow rate of 1.0 mL min-1. Detection was achieved 
with a photodiode array detector at 240 nm. The detector response for NTZ was 
linear over the concentration range from 2 to 100 µg mL -1 (r = 0.9999). The 
specificity and stability-indicating capability of the method were proved using 
stress conditions. The RSD values for intra-day precision were less than 1.0% for 
tablets and powder for oral suspension. The RSD values for inter-day precision 
were 0.6 and 0.7% for tablets and powder for oral suspension. The accuracy was 
100.4% (RSD = 1.8%) for tablets and 100.9% (RSD = 0.3%) for powder for oral 
suspension. The limits of quantization and detection were 0.4 and 0.1 µg mL -1. 
There was no interference of the excipients on the determination of the active 
pharmaceutical ingredient. The proposed method was precise, accurate, specific, 
and sensitive. It can be applied to the quantitative determination of drug in tablets 
and powder for oral suspension. 
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18. Evaluation of Nitazoxanide and Oxfendazole Efficacy against Cystic 
Echinococcosis in Naturally Infected Sheep35. 
Cesar M. Gavidia, et al; developed a method to determine the efficacy of 
nitazoxanide (NTZ) and oxfendazole (OXF) against CE in naturally infected 
sheep. A total of 151 ewes were assigned to the following groups: 15 mg/kg of 
NTZ weekly for five weeks (NTZ5); two rounds of 15 mg/ kg of NTZ a day for 
five days (NTZ5×2) two weeks apart; 30 mg/kg of OXF a week for 11 weeks 
(OXF11); 30 mg/kg of OXF plus 15 mg/kg of NTZ a week for 11 weeks 
(OXF/NTZ); and the control group. OXF11 and OXF/NTZ decreased the 
number of fertile cysts, increased the number of degenerated cysts, and were 
more efficacious (49.6–61.2%) against lung cysts and liver cysts (91.8–100%) 
than any other treatment group. OXF might be an additional strategy for control 
programs and an optional treatment of human CE after it is licensed. 
 
19. High dose prolonged treatment with nitazoxanide is not effective for 
cryptosporidiosis in HIV positive Zambian children: a randomized controlled 
trial36. 
 
Beatrice Amadi, et al; carried out a double-blind, randomized, placebo 
controlled trial in paediatric patients which was shown to be positive for both 
HIV and cryptosporidiosis, in the children's diarrhoea/malnutrition ward of the 
University Teaching Hospital, Lusaka. Children were included if between           
1 and 11 years of age, if positive in at least 2 of 3 stool samples 
for Cryptosporidium spp. (oocysts identified using auramine phenol staining), if 
they had diarrhoea with 3 or more unformed stools daily, and if HIV 
seropositive as confirmed by the Capillus Rapid Test (Trinity Biotech, Ireland). 
If Cryptosporidium spp. oocysts were present in the initial screening but not in 
the baseline samples, the patient was excluded unless they tested positive                
for oocysts within one week from this first sample. Children were                  
excluded if they had a bacterial cause for diarrhoea or if positive 
for Entamoebahistolytica or Giardia lamblia by the Triage Parasitic Panel 
(Biosite Diagnostics, San Diego, CA). Other exclusion criteria were a history of 
investigational drug therapy within one month prior to enrolment, or other 
recognised anti-protozoal therapy within two weeks prior to enrolment. Children 
who were moribund were not randomised and gravely ill were observed for a 
period of 1-2 weeks prior to randomisation. 
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20. Stability indicating CZE method and stress release degradation studies of 
Nitazoxanide37. 
Marcelo DonadelMalesuika, et al; devoloped and validated a new, simple, and 
effective stability-indicating CZE method for the determination of nitazoxanide 
in pharmaceutical formulations, using nimesulide as an internal standard. The 
optimum separation was carried out on a fused silica capillary 
(48.5 cm × 75 μmi.d., effective length 40 cm) maintained at 25°C, and a running 
electrolyte containing sodium acetate buffer (pH 5.2; 30 mM)-acetonitrile 
(80:20, v/v). The injections of the samples were performed using the pressure 
mode at 50 mm bar for 5 s, with detection at 360 nm using a photo-diode array 
detector. The method was suitably validated for specificity, linearity, precision, 
and accuracy, limit of detection and quantitation, and robustness. The high 
sensitivity of the method was proven with the limit of detection (0.05 μg mL−1) 
and quantitation (0.2 μg mL−1). The stability-indicating capability of the 
method was proven using stress conditions (acid and basic hydrolysis, oxidation, 
and photolysis). The proposed method was successfully applied for the 
determination of nitazoxanide in coated tablets and oral suspension powder. 
 
21. Liquid chromatography–tandem mass spectrometry analysis of nitazoxanide 
and its major metabolites in goat38. 
Zhanzhong Zhao, et al; devoloped a rapid, sensitive and specific liquid 
chromatography–electrospray ionization (ESI) tandem mass spectrometry (LC–
MS–MS) method for the identification of nitazoxanide metabolites in goat 
plasma and urine. The purified samples were separated using an XTerra MS C8 
column with the mobile phase consisted of acetonitrile and 10-mM ammonium 
acetate buffer (pH 2.5) followed a linear gradient elution, and detected by MS–
MS. Identification and structural elucidation of the metabolites were performed 
by comparing their retention-times, full scan, product ion scan, precursor ion 
scan and neutral loss scan MS–MS spectra with those of the parent drug or other 
available standard. Four metabolites (tizoxanide, tizoxanideglucuronide, 
tizoxanide sulfate and hydroxylatedtizoxanide sulfate) were found and identified 
in goat after single oral administration of 200 mg/kg dose of nitazoxanide. In 
addition, the possible metabolic pathway was proposed for the first time. The 
results proved that the established method was simple, reliable and sensitive, 
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revealing that it could be used to rapid screen and identify the structures of 
active metabolites responsible for pharmacological effects of nitazoxanide and 
to better understand its in vivo metabolism. 
 
22. Nitazoxanide for the treatment of Giardia Duodenalis infection: A 
comparative trial with Secnidazole39. 
Maria Elena Gonzalezi, et al; carried out  a randomized controlled open-label 
trial at the Cuban Institute of Gastroenterology in adults with confirmed Giardia 
duodenalis mono-infection. 125 patients were randomly assigned to receive 
either NTZ [500 mg two times daily for three days (n= 62)] or SNZ [2 g single 
dose (n= 63)]. The evaluation of the efficacy was based on parasitological 
response. All patients were asked to provide three faecal samples on days 3, 5, 
and 10 after treatment completion. Patients were considered to be cured if no 
Giardia trophozoites or cysts were found in any of the three post-treatment 
faecal specimens evaluated by direct wet mounts and/or after Ritchie 
concentration techniques. 
 
23. Development of Visible Spectrophotometric Methods for the Estimation of 
Nitazoxanide in Bulk and Pharmaceutical Formulation Using Ferric 
Chloride40. 
Sharma S, et al; developed a simple, accurate, precise and economical procedure 
for UV, simultaneous estimation of first and second derivative of Nitazoxanide 
single component tablet dosage form has been developed utilizing concept of 
standard addition. The method is based upon determination of Nitazoxanide at 
218.5 nm absolute ethanol. Nitazoxanide at their respective 8 max 274 nm and 
297 nm shows linearity in the concentration range of 5-30μg/ml. For the second 
method, first derivative Spectrophotometry, the response (dA/d8) of standard 
solutions was measured at 277 nm. Calibration curve was constructed by 
plotting dA/d8 values against concentrations, 5-40 μgmlG1 of Nitazoxanide 
standards in ethanol. For second derivative spectrophotometry, the response (d 
A/d8) of standard solutions was measured at 314 nm. The method was validated 
statistically and recovery study was performed to confirm the accuracy of the 
method. 
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24.  Development and Validation of a Dissolution method with Isocratic High-
Performance Liquid Chromatographic Determination of Nitazoxanide and 
Ofloxacin in Pharmaceutical Dosage form41. 
Sharma M.C, et al.,  devoloped a simple, specific, accurate and precise Isocratic 
reverse phase high pressure liquid chromatographic method for the simultaneous 
determination of Nitazoxanide and Ofloxacin from combined dosage form by 
reverse phase separation on columns containing different stationary phases, the 
final choice giving satisfactory resolution and run time was the 25 cm × 4.6 mm 
i.d, 5-μm particle; Phenomenex Luna C18 reversed-phase column. 2.0gm 
sodium dihydrogen phosphate and 5M of triethylamine are mixed into 500mL 
Milli Q water and pH was adjusted to 4.5 by orthophosphoric acid and diluted to 
1000mL as a mobile phase at a flow rate of 1.2ml/min and detection at 246nm. 
The average retention times for amoxicillin (Internal standard), Nitazoxanide 
and Ofloxacin was found to be 3.11, 5.28 and 7.31 min, respectively and 
recoveries from combined dosage form were between 98 and 102%. 
Quantification and linearity was achieved at 276 nm over the concentration 
range of 100-400 μg mLG1 for Nitazoxanide and 10-150 μg mLG1 for 
Ofloxacin. The method was validated for specificity, linearity, accuracy, 
precision, LOD, LOQ and robustness. The proposed method was optimized and 
validated as per the ICH guidelines. The method can be used for estimation of 
combination of these drugs in combined dosage form. 
 
25. A Validated Stability Indicating RP-LC Method for Nitazoxanide, a New Ant 
parasitic Compound42. 
Ashok S. Jadhav, et al; devoloped a method in which the drug substance was 
subjected to stress conditions of hydrolysis, photolysis and thermal degradation. 
The considerable degradation of nitazoxanide was observed under base and 
peroxide hydrolysis. The drug was found to be stable in other stress conditions 
attempted. The chromatographic separation of the drug was achieved on 
reversed-phase C-18 column. Eluents were monitored on photo-diode array 
detector at a wavelength of 240 nm. The mobile phase was aqueous 0.005 M 
tetra butyl ammonium hydrogen sulphate and acetonitrile (45:55, v/v). In the 
developed HPLC method, resolution between nitazoxanide and its potential 
impurities, namely Imp-A (5-nitro-1,3-thiazol-2-amine), Imp-B (N-(5-nitro-1,3-
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thiazol-2-yl) acetamide) and Imp-C (2-{[(5-nitro-1,3-thiazol-2-yl) amino] 
carbonyl} phenyl 2-(acetyloxy) benzoate) was found greater than three. The 
developed RP-HPLC method was validated with respect to response function, 
accuracy, precision, specificity, stability of analytical solutions and robustness. 
Also to determine related substances and assay determination of nitazoxanide 
that can be used to evaluate the quality of regular production samples. The 
developed method can also be conveniently used for the assay determination of 
nitazoxanide in pharmaceutical formulations. 
 
26. Method Development and Validation for Assay of Nitazoxanide in Tablet 
Using RP-HPLC43. 
Valarmathy J, developed a simple, selective, rapid, precise and accurate reverse 
phase high pressure liquid chromatographic method for the assay of 
nitazoxanide (NTZ) in tablets. An isocratic LC separation was performed on a 
inertsil C18 (250mm×4.6mm) Column with mobile phase consisting of 0.005M 
tetra butyl ammonium hydrogen sulphate (45): acetonitrile (55): at a flow rate at 
1.0 (ml/min). Detection was carried out at 345 nm. The retention time of 
nitazoxanide was 7.468 min respectively. The developed method was validated 
for linearity, accuracy, precision, solution stability, robustness, ruggedness. 
There was no interference of excipients on the determination of active 
pharmaceutical ingredients. It can be applied to the quantitative determination of 
drug in tablets and powder for oral suspension. 
 
27. RP-HPLC Determination of Nitazoxanide in Bulk and Different Tablet 
Formulations44. 
Vijay Y. Jadhav, et al; devoloped  a  simple,  accurate and  precise  validated  
RP-HPLC  method  for the  determination  of Nitazoxanide. Analysis was 
carried out on Jasco HPLC system with HiQ-sil C18 column (250 x 4.6 mm i.d.) 
using Acetonitrile: 0.005 mol.L–1 Tetrabutyl ammonium hydrogen sulphatein 
ratio of 55:45 v/v as mobile phase and Satranidazole as an internal standard. The 
detection  was  carried  out  using  UV  detector  set  at  240  nm.  For  this  
method,  Beer’s  law  is obeyed  in  the  concentration  range  of  5.0  to  30.0g  
mL–1 of  Nitazoxanide.  The  developed method  has  been  successfully  
applied  for  the  analysis  of  drug  in  bulk  and  pharmaceutical formulations. 
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The mean percent recoveries were found to be 100.19. 0.584 for Brand 1 and 
100.26. 1.1341 for Brand 2. The method was validated with respect to linearity, 
precision and accuracy as per the International Conference on Harmonisation 
(ICH) guidelines. 
 
28. Development and validation of nitazoxanide in tablet dosage form.45 
Sonal Bhale, et al; put forwarded a simple, precise, accurate, rapid and 
reproductive RPHPLC procedure for the determination of Nitazoxanide (NTZ) 
in tablet dosage form at a single wavelength. The mobile phase used was a 
combination of methanol: water: acetonitrile (30:40:30% v/v/v). The detection 
of NTZ was carried out at 330nm & flow rate was set to 1ml/min. Linearity was 
obtained in the concentration range of 5‐25ug/ml of NTZ with correlation 
coefficients of 0.9948. The results of the analysis were tested and validated 
statistically for various parameters according to ICH guidelines and recovery 
studies confirmed the accuracy of the proposed method. 
 
29. RP-HPLC methods for estimation of Nitazoxanide single and simultaneous 
estimation of Nitazoxanide with Ofloxacin in pharmaceutical dosage forms46. 
Hemendra P. Singh, et al; devoloped two simple, selective, rapid, precise and 
economical reverse phase high-pressure liquid chromatography methods. First 
method for estimation of nitazoxanide and second method for simultaneous 
estimation of nitazoxanide & ofloxacin from pharmaceutical dosage forms. The 
first method carried out on a Hypersil BDS C8 column (5μ particles size) (250 
mm X 4.6 mm), with mobile phase consisting of acetonitrile: 0.2M potassium 
dihydrogen phosphate in ratio 70:30 (pH 3.0 adjusted with orthophosphoric 
acid) at a flow rate of 1.0ml/min. Detection was carried out at 319nm. The 
retention time of nitazoxanide was 4.51 min. First developed method cannot 
easily apply for the simultaneous estimation of nitazoxanide and ofloxacin. So 
second method carried out on same column but different mobile phase 
whichconsisting the acetonitrile: 0.2M potassium dihydrogen phosphate: 
methanol in ratio 70:10:20 (pH 3.5 adjusted with orthophosphoric acid) at a flow 
rate of 1.0ml/min. Detection was carried out at 302nm. The retention time of 
nitazoxanide and ofloxacin were 6.93 min and 9.32 min, respectively. The result 
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of analysis shows that the amounts of drugs were in good agreement with the 
labeled claim of the formulations. The method validation parameters checked as 
per the ICH guidelines. Thus the methods are specific and sensitive. 
 
 
30. Mixed Hydrotropy in Spectrophotometric Analysis of Nitazoxanide47 
Sherje AP, et al; investigated and illustrated the application of mixed 
hydrotropy. There was significant synergistic effect on enhancement in 
solubility of a poorly water soluble drug by mixing two hydrotropic agents. The 
enhancement in solubility of nitazoxanide was more than 10 and 12 folds in 1M 
sodium benzoate solution (SB) and 1M sodium salicylate (SS) solution, 
respectively as compared to its solubility in distilled water. The enhancement in 
the solubility of nitazoxanide in a mixed hydrotropic solutions (SB-SS) 
containing 1M sodium benzoate and 1M sodium salicylate was more than 17 
folds. Thus, a mixed hydrotropic solution of sodium benzoate and sodium 
salicylate was employed to carry out spectrophotometric analysis precluding use 
of organic solvents. The tablets containing nitazoxanide were analyzed 
successfully. Recovery studies and statistical data proved accuracy, 
reproducibility and the precision of the proposed method. The presence of 
hydrotropic agents did not interfere in the analysis. 
 
31. Stripping Voltammetric Methods for Determination of the Ant parasitic Drug 
Nitazoxanide in Bulk Form, Pharmaceutical Formulation and Human 
Serum48. 
Hanaa S. El-Desoky, et al; recorded the cyclic voltammograms of nitazoxanide 
at the hanging mercury drop electrode in the Britton-Robinson universal buffer 
of pH values 2 to 11 containing 20% (v/v) ethanol exhibited a single 4-electron 
irreversible cathodic peak corresponding to the reduction of its NO2  group to the 
hydroxylamine stage. Nitazoxanide was found to adsorb onto surface of the 
mercury electrode in a monolayer surface coverage of 3.16×10-10 mol cm-2 in 
which each adsorbed molecule occupies an area of 0.525 nm2. Based on its 
adsorption behavior onto the mercury electrode surface, validated linear sweep 
(LS), differential pulse (DP) and square wave (SW) adsorptive cathodic 
stripping voltammetric methods were described for determination of bulk 
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nitazoxanide. Limits of detection of 1.5×10-10, 2.4×10-10 and 3.0×10-11 mol L-
1 and limits of quantification of 5.0×10-10, 8.0×10-10 and 1.0×10-10 mol L-1 
nitazoxanide in the bulk form were achieved by means of the described LS, DP 
and SW adsorptive cathodic stripping voltammetric methods, respectively. The 
described methods were successfully applied for determination of nitazoxanide 
in its pharmaceutical formulation (Cryptonaz powder) and in spiked human 
serum without the necessity for sample pretreatment, time consuming extraction 
steps or formation of colored chromogens prior to the analysis. Besides, 
nitazoxanide was successfully determined without interference from its acid or 
base-induced degradation products indicating the stability-indicating power of 
the described voltammetric methods. 
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IV   AIM OF PRESENT STUDY 
  
No official methods have been mentioned in IP, BP for the estimation of 
nitazoxanide in raw materials and in pharmaceutical dosage forms. From the literature 
review it was revealed that there were only few HPLC and spectrophotometric methods 
reported. 
  
So there is a need to develop simple, rapid, reproducible and economic 
spectrophotometric methods for the estimation of nitazoxanide. 
 
 The aim of present study is to develop good analytical methods, having good 
accuracy and cost effectiveness for the determination of nitazoxanide in bulk drug and its 
pharmaceutical formulations. 
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V PLAN OF WORK 
 
 
The present work deals with the determination of three spectrophotometric methods. 
 
i. First method is based on the formation of Schiff’s base. 
ii. Second method is based on diazotization coupling method. 
iii. Third method is based on a simple spectrophotometric method. 
iv. Fourth method is Reverse-Phase High Performance Liquid Chromatography. 
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IV   INSTRUMENTS AND MATERIALS USED 
 
1. Perkin Elmer EZ 301-UV-Visible Double beam spectrophotometer 
2. Shimadzu - Analytical balance-0.1mg 
3. Shimadzu,Japan - Electronic balance AY220 
4. Micro pipette (1ml,0.02ml)  - Huawei 
5. Accu pipette (0.2ml)  - Huawei 
6. Zinc powder (AR) 
7. Conc. HCl (AR) 
8. 4-Hydroxy benzaldehyde (AR) 
9. Sodium nitrite (AR) 
10. Ammonium sulphamate (AR) 
11. Phluroglucinol (AR) 
12. Methanol (AR) 
13. Distilled water 
14. HPLC (Shimadzu) 
15. Dipottasium hydrogen phosphate:acetonitrile 
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VII    INTRODUCTION TO PRESENT STUDY 
 
Nitazoxanide49 is used for the treatment of diarrhea caused by Giardia lambia 
/intestinalis or Cryptosporidium parvum. This novel agent has a broad spectrum of 
activity against many other gastrointestinal pathogens, including bacteria, round worms, 
flat worms and flukes. Nitazoxanide is used in many areas of the world, especially in 
Central and South America, as broad-spectrum parasiticidal agents in adults and children. 
Chemically nitazoxanide is [2-[(5-nitro-1, 3-thiazol-2-yl) carbamoyl] phenyl] ethanoate. 
 
Absorption spectroscopy is considered as a versatile technique frequently used in 
pharmaceutical analysis. Using this technique many pharmaceutical substances can be 
determined by UV-visible spectrophotometry, HPLC with great precision and accuracy. 
 
1st Method:-It is based on the formation of Schiff’s base (Aromatic aldehydes react with 
aliphatic /aromatic amines to form a derivative known as Schiff’s base) 
 
In this method nitazoxanide was reduced by Zn dust and 5N HCl. The reduced 
nitazoxanide was condensed with 4-hydroxy benzaldehyde to produce light orange 
colored compound (Schiff’s base).The absorption of resultant light orange coloured 
product was measured at 460nm. 
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2nd Method: -It is based on diazotization & coupling method. In this method nitazoxanide 
was reduced by Zn dust and 5N HCl, and then it is diazotized with HNO2 and excess of 
HNO2 was destructed by ammonium sulphamate. The diazotized salt was coupled with 
phluroglucinol to form a light orange coloured dye having maximum absorbance at 
450nm. 
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3rd Method:-It is a simple spectrophotometric method using methanol as solvent. It 
shows maximum absorbance at 340nm. 
 
4th method:-A rapid, precise and accurate high performance liquid chromatographic 
method for the determination of nitazoxanide in bulk drug and pharmaceutical 
formulation. The devoloped method was validated in terms of different parameters. 
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Preparation of standard stock solution 
25mg of nitazoxanide was dissolved in 5ml of methanol and was treated with 
2.5ml 5N HCl and 200mg Zn powder with continuous stirring for 20mts at room 
temperature. It was then filtered and the residue was washed with methanol. Then the 
volume was made upto25ml with methanol (Stock solution Ι, 1000µg/ml) 
Absorption spectra of coloured species 
5ml of standard stock solution Ι was pipetted into 50ml volumetric flask and it 
was diluted to 50ml with methanol (Stock solution ΙΙ, 100µg/ml). From this 3ml was 
pipetted out into 10ml volumetric flask and 1ml of 2% 4-hydroxy benzaldehyde, 1ml of 
Conc.HCl were added and kept aside for 5mts. The volume was made up to 10ml with 
methanol. The final volume concentration of the solution was 30µg/ml. The absorbance 
was measured between 340-480nm against reagent blank. 
Readings were shown in table no:1 and plotted in graph no:1 
Absorption spectra for the drug nitazoxanide by using 4-hydroxy benzaldehyde 
Drug concentration-30µg/ml 
TABLE NO: 1 
          WAVELENGTH(nm)                  ABSORBANCE 
380 0.087 
390 0.094 
400 0.112 
410 0.139 
420 0.173 
430 0.214 
440 0.250 
450 0.285 
460* 0.291 
470 0.268 
480 0.233 
490 0.158 
500 0.090 
           The maximum absorbance was measured at 460nm. 
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Calibration curve for nitazoxanide using 4-hydroxy benzaldehyde 
 
GRAPH NO: 1 
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Effect of reagent concentration  
Choosing of correct reagent concentration was an important aspect in the 
colorimetric determination. The optimum concentration of reagent was chosen by adding 
1ml of reagent of different concentration .ie 1%, 2%, 3% of 4-hydroxy benzaldehyde 
solution in methanol with series concentration of drug solution. 
              The calibration curve for each concentration was prepared by using drug in the 
concentration range of 10-50µg/ml and the absorbance was measured at 460nm against 
reagent blank. The readings were recorded in table no: 2 graphically plotted in graph 
number 2. 
Data for calibration curve plot with different reagent concentration 
                                                     TABLE NO: 2 
Drug concentration 
(µg/ml) 
Absorbance of reagent concentration 
1% 2% 3% 
                    10                  0.062           0.092            0.184 
                    20               0.132           0.187            0.285 
                    30               0.204           0.277            0.403 
                    40               0.276           0.364            0.498 
                    50               0.347           0.455            0.530 
 
    The optimum concentration was found to be 2%,since it exhibits linearity 
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Calibration curve plot for nitazoxanide with different reagent concentration 
GRAPH NO: 2 
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Effect of reagent amount 
Addition of correct amount of reagent was an important aspect in this experiment. 
The optimum amount of reagent was fixed by constructing calibration curve. The 
calibration curve was prepared by employing the drug in the concentration range of 10-
50µg/ml with different amount of reagent.ie 0.5ml, 1ml, 1.5ml. The readings were 
recorded in table no: 3 and graphically plotted in graph no: 3             
 
TABLE NO: 3 
      Drug concentration 
          (  µg/ml) 
                         Absorbance at 460nm   
            0.5ml                 1ml     1.5ml 
                  10             0.124        0.092     0.105 
                  20             0.195        0.187     0.176 
                  30             0.293        0.277     0.223 
                  40             0.372        0.364     0.360 
                  50             0.435        0.455     0.475 
 
The optimum amount of reagent was found to be 1ml. 
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Calibration curve plot for nitazoxanide using different amounts of 2%reagent 
concentration 
GRAPH NO: 3 
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FIXATION OF VARIOUS PARAMETERS 
1. λmax(Wavelength maximum) 
 The absorption spectral data showed that the maximum absorbance was observed 
at 460nm when scanned between 380-500nm. 
2. Specific extinction coefficient 
 The specific extinction coefficient can be calculated by using the formula:- 
E1%1cm=A/IC 
 where, 
                  A-Absorbance 
                   I-Light pathlength expressed in cm 
                   C-Concentration of drug in g/100ml 
BEERS’S LAW PLOT 
Beer’s law states that the fraction of the monochromatic radiant energy absorbed 
on passing through a solution is directly proportional to concentration of the absorbent. 
                                        Log10 I0/It=K.C 
where, 
                   K-Proportionality constant 
                   C-Concentration 
                    I0-I intensity of incident light 
                    It-Intensity of transmitted light 
 Having fixed other parameter, Beer’s law plot was constructed by measuring the 
absorbance of various concentration of drug solution against reagent blank. 
 5ml of stock solution-1 was pipetted in 50ml volumetric flask and made upto 
50ml with methanol. The concentration of solution was 100µg/ml (Stock solution-II). 
From stock solution II, various aliquots of 1ml, 2ml, 3ml, 4ml and 5ml were pipetted out 
into a 10ml volumetric flask followed by addition of 1ml, 2% 4-hydroxybenzaldehyde 
and 1ml conc. HCl and kept aside for 5mts.The volume was made upto 10ml with 
methanol to produce concentration in the range of 10-50µg/ml.Absorbance of each 
solution was observed at 460nm against reagent blank. The readings were recorded in 
table no: 4 and graphically plotted in graph no: 4. 
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SCHEMATIC REPRESENTATION OF BEER’S LAW PLOT 
25mg of pure nitazoxanide        ♦     25ml (solution- I, 1000µg/ml) 
 
 5ml→50ml (solution-II, 100µg/ml) 
 
 
                         1ml                       2ml                 3ml               4ml              5ml                                          
    *        *          *               *   * 
 10ml                   10ml                  10ml           10ml            10ml 
                       (10µg/ml)           (20µg/ml)      (30µg/ml)     (40µg/ml)      (50µg/ml) 
♦200mg Zn powder+2.5ml 5N HCl+5ml methanol 
*1ml 2%4-hydroxy benzaldehyde+1ml Conc.HCl 
DATA FOR BEER’S LAW PLOT 
TABLE NO: 4 
      Drug concentration 
                (µg/ml) 
            Absorbance 
                   10                    0.092 
                   20                   0.185 
                   30                   0.277 
                   40                   0.363 
                   50                   0.455 
 
Beer’s law was obeyed in the concentration range of 10-50µg/ml 
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Calibration curve for nitazoxanide using 4-hydroxy benzaldehyde 
GRAPH NO: 4 
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ASSAY OF TABLET 
10 tablets of nitazoxanide were taken for analysis. The average weights of tablets 
were calculated and were powdered in a glass mortar. Tablet powder equivalent to 25mg 
was accurately weighed and dissolved in 5ml of methanol and treated with Zn powder 
(200mg) and 2.5ml 5N HCl with continuous stirring for 1hr at room temperature. It was 
filtered and the residue was washed with methanol and then the volume was made up to 
25ml with methanol (Solution-I). 5ml of stock solution-1 was pipetted into 50ml 
volumetric flask and the volume was made upto 50ml with methanol solution-II). From 
this 3ml was pipette out into 10ml volumetric flask followed by addition of 1ml 2%, 4-
hydroxy benzaldehyde and 1ml concentrated HCl and kept aside for 5mts. The volume 
was made up with methanol to produce final drug concentration of 30µg/ml. The 
absorbance of this solution was measured at 460nm against reagent blank. The same 
procedure was repeated 5 times. In similar manner standard absorbance was measured 
with pure drug in same final concentration that of assay method. The data for assay of 
tablet were recorded in table no: 5. 
 
STANDARD DILUTION 
 
25mg of pure nitazoxanide      ♦     25ml (solution-I, 1000µg/ml) 
 
 5ml→50ml (solution-II, 100µg/ml) 
                                                                    * 
                                                                   3ml→10ml (30µg/ml) 
 
♦200mg Zn powder+2.5ml 5N HCl+5ml methanol 
*1ml, 2% 4-hydroxy benzaldehyde+1ml Conc.HCl 
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TEST DILUTION 
25mg of pure nitazoxanide        ♦     25ml (solution- I, 1000µg/ml) 
 
 5ml→50ml (solution-II, 100µg/ml) 
* 
        3ml→10ml (30µg/ml) 
 
♦200mg Zn powder+2.5ml 5N HCl+5ml methanol 
*1ml ,2% 4-hydroxy benzaldehyde+1ml Conc. HCl 
 
 
 
CALCULATIONS 
                  Using the absorbance of the standard and sample solution, the content of 
tablet was calculated as follows:- 
 
The content of nitazoxanide present in each tablet of average weight =  
Test absorbance  
Std absorbance
 x 
Wt of std drugሺmgሻ
25
 x 
5 
10
 x 
25 
wt of tablet powder ሺmgሻ
 x Avg wt oftablet ሺmgሻ  
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DATA FOR ASSAY OF TABLET 
(Label claim: 500mg) 
 
TABLE NO: 5 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sl 
no: 
Brand 
name 
Avgwt 
of 
tablet 
(mg) 
Wt. of  
std 
drug 
(mg) 
Std 
absor
bance
Wt. of 
Tablet 
Powder 
(mg) 
Wt.of 
tab 
powder 
(mg) 
Content of 
drug in 
tablet 
(mg) 
Avg 
content 
(mg) 
 
1 
 
 
 
 
 
NIZONIDE 
-500mg 
 
 
 
 
 
1261.96 
 
 
 
 
 
25.9 
 
 
 
 
 
0.295 
 
62 
 
0.280 
 
500.37 
 
 
 
 
 
498.73 
 
2 
 
63 
 
0.285 
 
501.28 
 
3 
 
64 
 
0.288 
 
498.58 
 
4 
 
65 
 
0.292 
 
497.72 
 
5 
 
66 
 
0.297 
 
498.58 
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INTERFERENCE STUDIES 
The interference studies of additives used in the formation of tablet were done by 
distributing them individually in distilled water and set aside for 10mts before filtering. 
The filtrate was diluted and proceeded as per tablet assay and the absorbance was 
measured at 460nm against reagent blanks. 
 
This procedure was repeated 5 times of each additive and the average value for 
each additive was given the following table no: 6 
 
 
DATA FOR THE INTERFERENCE STUDIES 
TABLE NO: 6 
 
Sl 
no: 
Name of the excipients Absorbance at 460nm 
1 Talc 0.001 
2 Lactose 0.003 
3 Starch 0.002 
4 Magnesium state 0.002 
 
The results show that the effect of interference studies in this spectroscopic method was 
found to be negligible. 
 
 
RECOVERY STUDIES 
In order to justify the reliability and suitability of the proposed method, recovery 
studies were carried out. 
The recovery experiment was performed on nitazoxanide tablet. The powder 
equivalent to 25mg was accurately weighed and dissolved in 5ml methanol and was 
treated with 200mg  Zn powder and 2.5ml 4N HCl with continuous stirring for 1hr at 
room temperature. It was filtered and washed with methanol. An aliquot of 5ml of 
                    
METHODOLOGY-I 
 
Department of Pharmaceutical Chemistry                                                         Page56 
 
standard solution (1mg/ml) of pure sample of nitazoxanide was added to the flask. It was 
shaken well and the volume was made upto 25ml with methanol and the procedure for 
the assay of nitazoxanidewas followed. The experiment was repeated 5 times. The results 
were recorded in table no: 7. The percentage recovery was calculated by using the 
formula:- 
% of Recovery= ୅୴୥ ୡ୭୬୲ୣ୬୲ ୤୰୭୫ ୰ୣୡ୭୴ୣ୰୷ି୅୴୥ ୡ୭୬୲ୣ୬୲ ୤୰୭୫ ୟୱୱୟ୷
୅୫୭୳୬୲ ୭୤ ୱ୲ୢ ୢ୰୳୥ ୟୢୢୣୢ
 x 100 
 
 
 
TABLE NO: 7 
 
 
 
 
 
 
 
Sl 
no: 
Brand 
name 
Avgwt 
of 
tablet 
(mg) 
Wt. of 
std 
drug 
(mg) 
Std 
absor
bance
Wt. of 
tablet 
powder 
(mg) 
Pure 
drug 
added
Abs of 
recovered 
sample 
 
%recovery 
 
1 
 
 
 
 
 
NIZONIDE 
-500mg 
 
 
 
 
 
1261.96 
 
 
 
 
 
  25.7 
 
 
 
 
 
0.302 
 
63.3 
 
5 
 
0.298 
 
 
 
 
 
104.93% 
 
2 
 
63 
 
5 
 
0.296 
 
3 
 
64 
 
5 
 
0.300 
 
4 
 
64.1 
 
5 
 
0.301 
 
5 
 
63.6 
 
5 
 
0.299 
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STANDARD DEVIATION 
                   It is determined by assaying a sufficient number of aliquots of a homogenous 
sample to be able to calculate statistically valid estimation of the standard deviation 
using the formula:- 
 
                   SD = ඥࢳሺࢄି࢞ሻ૛
ࡺି૚
 
X-Observed value 
x-mean/arithmetic average 
N-Number of observations 
     The square root of standard deviation is called variance./The more 
accurate measure of precision is called Coefficiant of variation/%RSD 
                      %RSD= (SD/x) x 100 
 
PRECISION57 
                The precision of an analytical method is the degree of reproducibility among 
the individual test results when the procedure was applied repeatedly to multiple 
sampling of homogenous sample. The precision of an analytical method is usually 
expressed as standard deviation or percentage RSD of a series of measurements. 
The precision study was done based on the data obtained from table no: 7 and the 
results were shown in table no: 8 
TABLE NO: 8 
Sl no: Name of tablet 
Standard 
Deviation (SD) 
Coefficient of 
variation(%RSD) 
1 NIZONIDE 1.3623 0.2735 
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ACCURACY57 
 
Accuracy is the closeness of the test results obtained by the procedure to the true 
value. Accuracy of the proposed method was evaluated by comparing the average value 
obtained by the proposed method with that of reported method (standard method) and 
results were given table no: 9 
TABLE NO: 9 
Sl no: 
Amount obtained by standard 
method 
Amount obtained by proposed 
1 499.05mg 498.73mg 
 
 
STANDARD METHOD 
Preparation of standard 
10mg  of pure nitazoxanide was accurately weighed and transferred into 25ml 
volumetric flask  and made up to 10ml with DMF (stock solution-I). 1ml of solution-I 
was pipetted into 10ml volumetric flask and the volume was made up to 10ml with 
DMFsolution-II). From this 2ml was pipetted out into 10ml volumetric flask  and made 
upto 10ml with DMF. From this  again 2ml of the solution was pippeted out and made 
upto 10ml with DMF to produce final drug concentration of 4µg/ml. The absorbance of 
this solution was measured at 340nm against reagent blank 
 
ASSAY OF TABLET 
10 tablets of nitazoxanide were taken for analysis. The average weights of tablets 
were calculated and were powdered in a glass mortar. Tablet powder equivalent to 10mg 
was accurately weighed and dissolved in 5ml of DMF .It was filtered and the residue was 
washed with DMF and then the volume was made up to 10ml with DMF (Solution-I). 
1ml of solution-1 was pipette into 10ml volumetric flask and the volume was made upto 
10ml with DMFsolution-II). From this 2ml was pipette out into 10ml volumetric flask 
and made upto 10ml with DMF. From this 2ml of the solution was pippeted out and 
made upto 10ml with DMF to produce final drug concentration of 4µg/ml. The 
absorbance of this solution was measured at 340nm against reagent blank. The same 
procedure was repeated 5 times. In similar manner standard absorbance was measured 
with pure drug in same final concentration that of assay method. The data for assay of 
tablet were recorded in table no: 10. 
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STANDARD DILUTION 
 
25mgof pure nitazoxanide    25ml (Solution-I, 1000µg/ml) 
 
 
          1ml→10ml (Solution-II, 100µg/ml) 
 
 
                                                                       2ml→10ml (30µg/ml) 
 
 
                                                                                     2→10ml (4µg/ml) 
 
 
TEST DILUTION 
Tablet powder equivalent  
to 25mgnitazoxanide   25ml(Solution-I, 1000μg/ml) 
 
 
     1ml→10ml (Solution-II, 100µg/ml) 
 
 
                                                               2ml→10ml (30µg/ml) 
 
 
                                                                              2→10ml (4µg/ml) 
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CALCULATIONS 
                  Using the absorbance of the standard and sample solution, the content of 
tablet was calculated as follows:- 
 
The content of nitazoxanide present in each tablet of average weight =  
Test absorbance  
Std absorbance
 x 
Wt of std drugሺmgሻ 
25
 x 
5 
10
 x 
25 
wt of tablet powder ሺmgሻ
 x Avg wt oftablet ሺmgሻ  
 
 
DATA FOR ASSAY OF TABLET 
(Label claim: 500mg) 
TABLE NO: 10 
 
 
Sl 
no: 
Brand 
name 
Avgwt 
of 
tablet 
(mg) 
Wt. of 
std 
drug 
(mg) 
Std 
absor
bance
Wt. of 
tablet 
powder 
(mg) 
Wt.of 
tablet 
powder
Content 
of drug 
in 
tab(mg) 
Avg 
content 
(mg) 
 
1 
 
 
 
 
 
NIZONIDE 
-500mg 
 
 
 
 
 
1261.96 
 
 
 
 
 
  25.5 
 
 
 
 
 
0.243 
 
63.4 
 
0.239 
 
499.21 
 
 
 
 
 
499.05 
 
2 
 
63 
 
0.237 
 
498.18 
 
3 
 
64 
 
0.241 
 
498.67 
 
4 
 
63.5 
 
0.240 
 
500.51 
 
5 
 
63.2 
 
0.238 
 
498.70 
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IX METHODOLOGY II 
 
SPECTROPHOTOMETRIC DETERMINATION-II 
 
Spectrophotometric determination of nitazoxanide by diazotization coupling method 
using phluroglucinol56 
 
Chemical used 
1. Zinc granules (AR) 
2. Conc.HCl (AR) 
3. Sodium nitrite (AR) 
4. Ammonium sulphamate (AR) 
5. Phluroglucinol (AR) 
Chemical structure 
 
 
 
 
 
Chemical name 
             1, 3, 5 trihydroxy benzene/benzene 1, 3, 5 triol 
 
Molecular formula- C6H6O 
 
Molecular weight- 126.1 
 
Solubility-Freely soluble in alcohol and water 
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Preparation of 4N HCl 
             It was prepared by dissolving 34ml of conc.HCl in 100ml distilled water. 
 
Preparation of 0.1%w/v sodium nitrite 
              It was prepared by dissolving 0.1g of sodium nitrite in 100ml distilled water. 
Preparation of 0.5%w/v of ammonium sulphamate 
              It was prepared by dissolving 0.5g of ammonium sulphamate in 100ml distilled 
water. 
Preparation of 0.5%w/v phluroglucinol 
                 It was prepared by dissolving 0.5g of phluroglucinol in 100ml distilled water. 
Preparation of standard stock solution 
10mg of nitazoxanide was accurately weighed and dissolved in 5ml methanol. 
The methanolic solution of nitazoxanide was treated with 200mg of Zn powder and 
2.5ml of 4N HCl and kept aside for 1hour at room temperature. The solution was filtered 
and the volume was made up to 10ml with methanol. (1000µg/ml). 
 
Absorption spectra of coloured species 
5ml of standard stock solution I was pipette into 50ml volumetric flask and made 
up with methanol. From this 3ml was pipetted out into 10ml volumetric flask followed 
by the addition of 1ml conc:HCl, 1ml of 0.1%sodium nitrite, 1ml of 0.5%w/v ammonium 
sulphamate and 1ml of 0.5%w/v phluroglucinol were added. Finally the volume was 
made upto 10ml with methanol. The final concentration of the solution was 30µg/ml. 
The absorbance was scanned between 400-500nm against reagent blank. Readings were 
shown in table no: 11 and plotted in graph no: 5 
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TABLE NO: 11 
WAVELENGTH ABSORBANCE 
410 0.239 
420 0.246 
430 0.258 
440 0.276 
450* 0.283 
460 0.278 
470 0.265 
480 0.252 
490 0.240 
500 0.237 
 
The maximum absorbance was measured at 450nm. 
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Calibration curve for nitazoxanide using phluroglucinol 
 
GRAPH NO: 5 
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Effect of reagent concentration 
                               Choosing of correct reagent concentration was an important aspect in 
the spectrophotometric determination. The optimum concentration of reagent was chosen 
by adding 1ml of reagent of different concentration. i.e. 0.25%, 0.5%, 1% of 
phluroglucinol solution in methanol with series concentration of drug solution. 
                                 The calibration curve for each concentration was prepared by using 
drug in the concentration range of 10-50µg/ml and the absorbance was measured at 
450nm against reagent blank. The readings were recorded in table no: 12 and graphically 
plotted in graph number: 6. 
TABLE NO: 12 
Drug 
concentration(µg/ml) 
Effect of reagent concentration 
0.25% 0.5% 1% 
10 0.072 0.088 0.096 
20 0.082 0.173 0.183 
30 0.099 0.292 0.288 
40 0.149 0.333 0.364 
50 0.213 0.362 0.451 
 
The optimum concentration was found to be 1%.Since it exhibits linearity. 
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Calibration curve of nitazoxanide with different concentration of phluroglucinol 
 
GRAPH NO: 6 
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Effect of reagent amount 
Addition of correct amount of reagent was an important aspect in this experiment. 
The optimum amount of reagent was fixed by constructing calibration curve. The 
calibration curve was prepared by employing the drug in the concentration range of 10-
50µg/ml with different amount of reagent i.e.0.5ml, 1ml, 1.5ml.The readings were 
recorded in table no: 13 and graphically plotted in graph no: 7                               \ 
TABLE NO: 13 
Drug 
concentration(µg/ml 
Absorbance at 450nm 
0.5ml 1ml 1.5ml 
10 0.103 0.088 0.220 
20 0.154 0.16 0.293 
30 0.217 0.220 0.341 
40 0.264 0.278 0.380 
50 0.308 0.341 0.423 
 
The optimum amount of reagent was found to be 1ml 
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Calibration curve plot for nitazoxanide using different amounts of 2%reagent 
concentration 
 
GRAPH NO: 7 
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FIXATION OF VARIOUS PARAMETERS 
1. λmax(Wavelength maximum) 
The absorption spectral data showed that the maximum absorbance was observed 
at 460nm when scanned between 380-500nm. 
2. Specific extinction coefficient 
 The specific extinction coefficient can be calculated by using the formula. 
E1%1cm=A/IC 
 
 where, 
                  A-Absorbance 
                   I-Light path length expressed in cm 
                   C-Concentration of drug in g/100ml 
 
BEERS’S LAW PLOT 
 Beer’s law states that the fraction of the monochromatic radiant energy absorbed 
on passing through a solution is directly proportional to concentration of the absorbent. 
                                        Log10 I0/It=K.C 
where, 
                   K-Proportionality constant 
                   C-Concentration 
                    I0-I intensity of incident light 
                    It-Intensity of transmitted light 
Having fixed other parameter, Beer’s law plot was constructed by measuring the 
absorbance of various concentration of drug solution against reagent blank.  
5ml of stock solution-I was pipetted in 50ml volumetric flask and made upto 
50ml with methanol. The concentration of solution was 100µg/ml (Stock solution-II). 
From stock solution II, various aliquots of 1ml, 2ml, 3ml, 4ml and 5ml were pipette out 
into a 10ml volumetric flask followed by addition of 1ml of 0.1% NaNO2 and 1ml 
conc:HCl and kept aside for 5mts at room temperature. An aqueous solution of 1ml of 
0.5% ammonium sulphamate and 0.5% phluroglucinol were added. The volume was 
made upto 10ml with methanol to produce concentrations in the range of 10-50µg/ml 
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respectively. Absorbance of each solution was observed at 450nm against reagent as 
blank. Readings were shown in table no: 14 and readings were shown graphically in 
graph no: 8 
SCHEMATIC REPRESENTATION OF BEER’S LAW PLOT 
        ♦ 
10mg of pure nitazoxanide  10ml (solution- I, 1000µg/ml) 
 
  
    5ml                 50ml (solution-II, 100µg/ml) 
 
                              1ml                     2ml                 3ml                4ml               5ml                                      
    *                          *                     *                     *                  * 
   10ml                     10ml       10ml               10ml             10ml 
                      (10µg/ml)           (20µg/ml)      (30µg/ml)     (40µg/ml)      (50µg/ml) 
 
♦200mg Zn powder + 2.5ml 5N HCl + 5ml methanol 
*1ml conc: HCl + 1ml of 0.1% NaNO2 + 1ml of 0.5% ammonium sulphamate + 1ml of 
0.5 % phluroglucinol 
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DATA FOR BEER’S LAW PLOT 
TABLE NO: 14 
Drug concentration 
(µg/ml) 
Absorbance 
10 0.072 
20 0.148 
30 0.224 
40 0.295 
50 0.357 
 
Beer’s law was obeyed in the concentration range of 10-50µg/ml 
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Calibration curve for nitazoxanide using 4-hydroxy benzaldehyde 
        GRAPH NO:8 
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ASSAY OF TABLET 
10 tablets of nitazoxanide were taken for analysis. The average weights of tablets 
were calculated and were powdered in a glass mortar. Tablet powder equivalent to 10mg 
was accurately weighed and dissolved in 5ml of methanol and treated with Zn powder 
(200mg) and 2.5ml 5N HCl with continuous stirring for 1hr at room temperature. It was 
filtered and the residue was washed with methanol and then the volume was made up to 
10ml with methanol (Solution-I). 5ml of solution-I was pipette into 50ml volumetric 
flask and the volume was made upto 10ml with methanol (solution-II). From this 3ml 
was pipette out into 10ml volumetric flask followed by addition of 1ml of concentrated 
HCl, 1ml of 0.1% NaNO2 and kept aside for 5mts. Then an aqueous solution of 1ml of 
0.5% ammonium sulphamate and 1ml of 0.5% phluroglucinol were added. The volume 
was made up with methanol to produce final drug concentration of 30µg/ml. The 
absorbance of this solution was measured at 450nm against reagent blank. The same 
procedure was repeated 5 times. In similar manner standard absorbance was measured 
with pure drug in same final concentration that of assay method. The data for assay of 
tablet were recorded in table no: 15 
 
STANDARD DILUTION 
 
25mlgof pure nitazoxanide ♦      25ml (Solution-I, 1000µg/ml) 
 
         5ml          50ml (Solution-II, 100µg/ml) 
 
         3ml    *    10ml (30µg/ml) 
 
♦200mg Zn powder+2.5ml 5N HCl+5ml methanol 
*1ml conc: HCl+1ml 0f 0.1% NaNO2+ 1ml of 0.5% ammonium sulphamate+1ml of 
0.5%phluroglucinol. 
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TEST DILUTION 
Tablet powder equivalent to  
25mg of pure nitazoxanide ♦      25ml (Solution-I, 1000µg/ml) 
 
         5ml          50ml (Solution-II, 100µg/ml) 
 
        3ml    *    10ml (30µg/ml) 
 
♦200mg Zn powder+2.5ml 5N HCl+5ml methanol 
*1ml conc:HCl+1ml 0f 0.1% NaNO2+ 1ml of 0.5% ammonium sulphamate+1ml of 
0.5%phluroglucinol. 
CALCULATIONS 
Using the absorbance of the standard and sample solution, the content of tablet 
was calculated as follows:- 
 
The content of nitazoxanide present in each tablet of average weight =  
Test absorbance  
Std absorbance
 x 
Wt of std drugሺmgሻ 
25
 x 
5 
10
 x 
25 
wt of tablet powder ሺmgሻ
 x Avg wt oftablet ሺmgሻ  
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DATA FOR ASSAY OF TABLET 
(Label claim: 500mg) 
 
TABLE NO: 15 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sl 
no: 
Brand 
name 
Avgwt 
of 
tablet(
mg) 
Wt of 
std 
drug 
(mg) 
Std 
absor
bance
Wtof tab 
powder 
(mg) 
Wt.of 
tablet 
powder 
Content 
of drug 
in 
tab(mg) 
Avg 
content
(mg) 
 
1 
 
 
 
 
 
NIZONIDE 
-500mg 
 
 
 
 
 
1261.96 
 
 
 
 
 
  10 
 
 
 
 
 
0.214 
 
25 
 
0.211 
 
497.70 
 
 
 
 
 
498.097 
 
2 
 
24.8 
 
0.209 
 
496.96 
 
3 
 
25.1 
 
0.212 
 
498.07 
 
4 
 
25.1 
 
0.213 
 
500.42 
 
5 
 
24.9 
 
0.210 
 
497.34 
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INTERFERENCE STUDIES 
The interference studies of additives used in the formation of tablet were done by 
distributing them individually in distilled water and set aside for 10mts before filtering. 
The filtrate was diluted and proceeded as per tablet assay and the absorbance was 
measured at 460nm against reagent blanks. 
This procedure was repeated 5 times of each additive and the average value for 
each additive was given the following table: 16 
 
 
DATA FOR THE INTERFERENCE STUDIES 
TABLE NO: 16 
 
 Name of the excipients          Absorbance at 460nm 
1 Talc            0.002 
2 Lactose            0.001 
3 Starch            0.003 
4 Magnesium sterate            0.001 
 
The results show that the effect of interference studies in this spectroscopic method was 
found to be negligible. 
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RECOVERY STUDIES 
 
In order to justify the reliability and suitability of the proposed method, recovery 
studies were carried out. 
The recovery experiment was performed on nitazoxanide tablet. The powder 
equivalent to 25mg was accurately weighed and dissolved in 5ml methanol and was 
treated with 200mg  Zn powder and 2.5ml 4N HCl with continuous stirring for 1hr at 
room temperature. It was filtered and washed with methanol. An aliquot of 5ml of 
standard solution (1mg/ml) of pure sample of nitazoxanide was added to the flask. It was 
shaken well and the volume was made upto 25ml with methanol and the procedure for 
the assay of nitazoxanidewas followed. The experiment was repeated 5 times. The results 
were recorded in table no: 17. The percentage recovery was calculated by using the 
formula:- 
 
 
% of Recovery= ୅୴୥ ୡ୭୬୲ୣ୬୲ ୤୰୭୫ ୰ୣୡ୭୴ୣ୰୷ି୅୴୥ ୡ୭୬୲ୣ୬୲ ୤୰୭୫ ୟୱୱୟ୷
୅୫୭୳୬୲ ୭୤ ୱ୲ୢ ୢ୰୳୥ ୟୢୢୣୢ
 x 100 
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DATA FOR THE RECOVERY STUDY OF NITAZOXANIDE TABLET 
TABLE NO: 17 
 
 
STANDARD DEVIATION 
                   It is determined by assaying a sufficient number of aliquots of a homogenous 
sample to be able to calculate statistically valid estimation of the standard deviation 
using the formula:- 
          SD = ඥࢳሺࢄି࢞ሻ૛
ࡺି૚
 
X-Observed value 
x-mean/arithmetic average 
N-Number of observations 
     The square root of standard deviation is called variance. The more 
accurate measure of precision is called Coefficient of variation/%RSD 
          %RSD= (SD/x) x100 
 
 
Sl 
no: 
Brand 
name 
Avgwt 
of 
tablet 
(mg) 
Wt.ofs
td 
drug 
(mg) 
Std 
absor
bance
Wt.of 
tablet 
powder 
(mg) 
Pure 
drug 
added 
Abs of 
recovered 
sample 
(mg) 
%recovery 
 
1 
 
 
 
 
 
NIZONIDE 
-500mg 
 
 
 
 
 
1261.96 
 
 
 
 
 
  25.7 
 
 
 
 
 
0.302 
 
63.3 
 
5 
 
0.298 
 
 
 
 
 
104.93% 
 
2 
 
63 
 
5 
 
0.296 
 
3 
 
64 
 
5 
 
0.300 
 
4 
 
64.1 
 
5 
 
0.301 
 
5 
 
63.6 
 
5 
 
0.299 
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PRECESION57 
              The precision of an analytical method is the degree of reproducibility among the 
individual test results when the procedure was applied repeatedly to multiple sampling of 
homogenous sample. The precision of an analytical method is usually expressed as 
standard deviation. 
 
  The precision study was done based on the data obtained from table no: 15 and 
the results were shown in table No: 18 
TABLE NOS: 18 
 
Sl  no: Name of tablet 
Standard 
deviation 
(SD) 
Coefficient of 
variation(%RSD) 
 
1 
 
NIZONIDE 
 
0.9436 
 
0.1891 
 
 
ACCURACY57 
                Accuracy is the closeness of the test results obtained by the procedure to that 
true value. Accuracy of the proposed method was evaluated by comparing the average 
value obtained by the proposed method with that of reported method (standard method) 
and results were given table no: 19 
TABLE NO: 19 
 
Sl no: 
Amount obtained by std 
method 
Amount obtained by proposed 
1 499.05mg 498.09mg 
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X METHODOLOGY – III 
 
SPECTROPHOTOMETRIC DETERMINATION OF NITAZOXANIDE USING 
METHANOL AS SOLVENT56 
 
Preparation of standard stock solution 
                 10mg of nitazoxanide was accurately weighed and dissolved in 5ml methanol 
and was made up to 10ml with methanol. (1000µg/ml) 
Absorption spectra 
                 From that 1ml was pippeted out and made up to 10ml with methanol. Then 
pippeted out 2ml and again made up with 10ml.The final concentration was 4µg/ml.The 
absorbance was scanned between 300-400nm against reagent blank. Readings were 
plotted in table no: 20 and shown in graph no: 9 
TABLE NO: 20 
 
The maximum absorbance was measured at 340nm 
 
 
 
 
WAVELENGTH ABSORBANCE 
300 0.235 
310 0.238 
320 0.254 
330 0.276 
340* 0.283 
350 0.278 
360 0.260 
370 0.245 
380 0.230 
390 0.219 
400 
 
0.216 
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Calibration curve for nitazoxanide by using methanol as solvent 
 
GRAPH NO: 9 
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DATA FOR BEER’S PLOT 
 
TABLE NO: 21 
      Drug concentration 
                (µg/ml) 
            Absorbance 
                   2                    0.106 
                   4                   0.207 
                   6                   0.307 
                   8                   0.406 
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Calibration curve for nitazoxanide by using methanol as solvent 
 
GRAPH NO:10 
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ASSAY OF TABLET 
10 tablets of nitazoxanide were taken for analysis. The average weights of tablets 
were calculated and were powdered in a glass mortar. Tablet powder equivalent to 10mg 
was accurately weighed and dissolved in 5ml of methanol. It was filtered and the residue 
was washed with methanol and then the volume was made up to 10ml with methanol 
(Solution-I). 1ml of solution-I was pipetted into 10ml volumetric flask and the volume 
was made upto 10ml with methanol (solution-II). From this 2ml was pipette out into 
10ml volumetric flask and made upto 10ml with methanol. From this 2ml of the solution 
was pippeted out and made upto 10ml with methanol to produce final drug concentration 
of 30µg/ml. The absorbance of this solution was measured at 340nm against reagent 
blank. The same procedure was repeated 5 times. In similar manner standard absorbance 
was measured with pure drug in same final concentration that of assay method. The data 
for assay of tablet were recorded in table no: 22 
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STANDARD DILUTION 
 
25mg of pure nitazoxanide   25ml (Solution-I, 1000μg/ml) 
 
1ml  10ml (Solution-II, 100µg/ml) 
 
       2ml             10 ml (30µg/ml) 
 
             2ml  10ml (4µg/ml) 
 
TEST DILUTION 
Tablet powder equivalent to  
25mg of pure nitazoxanide       25ml (Solution-I, 1000µg/ml) 
 
        1ml        10ml (Solution-II, 100µg/ml) 
 
              2ml             10 ml (30µg/ml) 
 
             2 ml          10ml (4µg/ml) 
 
CALCULATIONS 
                  Using the absorbance of the standard and sample solution, the content of 
tablet was calculated as follows:- 
 
The content of nitazoxanide present in each tablet of average weight =  
Test absorbance  
Std absorbance
 x 
Wt of std drugሺmgሻ 
25
 x 
5 
10
 x 
25 
wt of tablet powder ሺmgሻ
 x Avg wt oftablet ሺmgሻ  
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DATA FOR ASSAY OF TABLET 
(Label claim: 500mg) 
 
TABLE NO: 22 
 
 
 
 
 
 
  
Sl 
no 
Brand 
name 
Avgwt 
of 
tablet(
mg) 
Wt of 
std 
drug 
(mg) 
Std 
absor
bance
Wtof tab 
powder 
(mg) 
Wt.of 
tablet 
powder
Content 
of drug 
in 
tab(mg) 
Avg 
content
(mg) 
 
1 
 
 
 
 
 
NIZONIDE 
-500mg 
 
 
 
 
 
1261.96 
 
 
 
 
 
25.5 
 
 
 
 
 
0.201 
 
   63.3 
 
0.197 
 
498.25 
 
 
 
 
 
498.818 
 
2 
 
   62.4 
 
0.195 
 
500.31 
 
3 
 
   63.5 
 
0.198 
 
499.20 
 
4 
 
   63 
 
0.196 
 
498.08 
 
5 
 
   63.3 
 
0.197 
 
498.25 
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RECOVERY STUDIES 
 
                    In order to justify the reliability and suitability of the proposed method, 
recovery studies were carried out. 
 
                    The recovery experiment was performed on nitazoxanide tablet. The powder 
equivalent to 25mg was accurately weighed and dissolved in 5ml methanol and made up 
with 25ml methanol. An aliquot of 1ml of standard solution was pippeted out and made 
up with 10ml methanol and the volume was made upto 25ml with methanol and the 
procedure for the assay of nitazoxanide was followed. The experiment was repeated 5 
times. The results were recorded in table no: 24. The percentage recovery was calculated 
by using the formula:- 
 
% of Recovery= ୅୴୥ ୡ୭୬୲ୣ୬୲ ୤୰୭୫ ୰ୣୡ୭୴ୣ୰୷ି୅୴୥ ୡ୭୬୲ୣ୬୲ ୤୰୭୫ ୟୱୱୟ୷
୅୫୭୳୬୲ ୭୤ ୱ୲ୢ ୢ୰୳୥ ୟୢୢୣୢ
 x 100 
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DATA FOR THE RECOVERY STUDY OF NITAZOXANIDE TABLET 
TABLE NO: 24 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sl 
no: 
Brand 
name 
Avgwt 
of 
tablet 
(mg) 
Wt of 
std 
drug 
(mg) 
Std 
absor
bance
Wt of 
tablet 
powder 
(mg) 
Pure 
drug 
added 
Abs of 
recovered 
sample 
 
%recovery 
 
1 
 
 
 
 
 
NIZONIDE 
-500mg 
 
 
 
 
 
1261.96 
 
 
 
 
 
  25.7 
 
 
 
 
 
0.302 
 
   63.3 
 
 5 
 
0.211 
 
 
 
 
 
100.48% 
 
2 
 
63.8 
 
 5 
 
0.213 
 
3 
 
63 
 
 5 
 
0.210 
 
4 
 
   63.3 
 
 5 
 
0.212 
 
5 
 
   62.8 
 
 5 
 
0.209 
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STANDARD DEVIATION 
                   It is determined by assaying a sufficient number of aliquots of a homogenous 
sample to be able to calculate statistically valid estimation of the standard deviation 
using the formula:- 
                SD = ඥࢳሺࢄି࢞ሻ૛
ࡺି૚
 
X-Observed value 
x-mean/arithmetic average 
N-Number of observations 
     The square root of standard deviation is called variance. The more 
accurate measure of precision is called Coefficient of variation/%RSD 
 
               %RSD= (SD/x) x100 
 
PRECESION57 
The precision of an analytical method is the degree of reproducibility among the 
individual test results when the procedure was applied repeatedly to multiple sampling of 
homogenous sample.The precision of an analytical method is usually expressed as 
standard deviation. 
 
The precision study was done based on the data obtained from table no: 22 and 
the results were shown in table No: 25 
TABLE NO: 25 
 
 
Sl no: 
 
Name of tablet 
Standard 
Deviation 
       (SD) 
Coefficient of 
variation(%RSD) 
 
1 
 
NIZONIDE 
 
0.9484 
 
0.1893 
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ACCURACY57 
                Accuracy is the closeness of the test results obtained by the procedure to that 
true value. Accuracy of the proposed method was evaluated by comparing the average 
value obtained by the proposed method with that of reported method (standard method) 
and results were given table no: 26 
 
TABLE NO: 26 
 
Sl no: 
Amount obtained by std 
method 
Amount obtained by proposed 
1 499.05mg 498.818mg 
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XI   METHODOLOGY IV 
 
RP-HPLC DETERMINATION OF NITAZOXANIDE IN BULK AND 
TABLET FORMULATION. 
 
Materials required 
1. Balance-Electronic balance (Shimadzu) 
2. HPLC Separation module (Shimadzu) 
3. Detector-UV (254nm) 
4. Chromatographic data software- Spin chrome CFR 
5. Column- C18 
Reagents required 
1. Acetonitrile (HPLC grade) 
2. Dipottasium hydrogen phosphate 
 
Reference standard used 
Nitazoxanide (Lupin Pharmaceuticals, Pondicherry) 
 
Tablet brand used 
NIZONIDE-500mg 
 
Chromatographic conditions 
A chromatographic system (Shimadzu, Japan) consisting of a solvent 
delivery pump, a degasser, an injector, an RP column, UV detector. An ODS 
(octadecylsilane) packed C18 column was used for separation. The instrumental 
settings were at the flow rate of 1.2ml/mt. The injection volume was 20µl. The 
peak purity was checked with the UV detector (SPD 20A). Detection was 
performed at 254nm. Software used is Spin chrome. 
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Selection of wavelength 
           From the UV spectrum of the compound, the λmax of nitazoxanide was 
found to be 254nm and that wavelength is suitable for detection. So the 
appreciable absorbance was found at 254nm. 
 
Preparation of Mobile phase 
       The mobile phase consisted of dipottasium hydrogen phosphate buffer 
and acetonitrile in the ratio (70:30). The mobile phase was premixed and filtered 
through a nylon filter and degassed. 
 Preparation of buffer 
             Dipottasium hydrogen phosphate was prepared as per IP and PH was 
adjusted to 6.8. 
 
Preparation of Standard solution 
              Standard solution was prepared by dissolving 100mg of nitazoxanide in 
methanol and it was made up to 100ml with methanol (1000µg/ml) 
 
Preparation of test solution 
    Tablet powder equivalent to100mg of pure nitazoxanide was accurately 
weighed and transferred into a volumetric flask, dissolved in small volumes of 
diluents and volume was made up with methanol. 
 
Method development 
    A rapid HPLC method was devoloped and validated for the estimation 
of nitazoxanide. A  C18 column with mobile phase containing mixureof buffer 
and acetonitrile was used. Mobile phase was pumped at the flow rate of  1.2ml/mt 
and the eluents were monitored at 254nm with 20µl loop injector. The selected 
chromatographic condition were found to effectively separate nitazoxanide. The 
method validated in the terms of no: of theoretical plates, tailing factor, linearity, 
correlation coefficient, limit of detection (LOD) limit of quantitation (LOQ) for 
nitazoxanide. 
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            Limit of Quantitation (LOQ) 58, 59 
           It is a characteristic of quantitative assays for low level of 
compounds in sample matrices, such as impurities in bulk drug and degradation 
products in finished pharmaceuticals. It is the lowest level of analyte in a sample 
that can be determined with acceptable precision and accuracy under the stated 
experimental conditions. The quantitation limits is expressed as concentration of 
analyte (e.g.: percentage, parts per billion) in sample. 
Determination: For instrumental and non-instrumental methods, LOQ is 
determined by analysis of sample with known concentration of analyte and by 
establishing the minimum level at which the analyte can be determined with 
acceptable accuracy and precision. 
LOQ = 3.3 x Standard deviation 
                             Slope 
 
            Limit of Detection (LOD)58, 59 
It is a characteristic of limit tests. It is the lowest amount of the analyte in 
a sample that can be detected, but not necessarily quantitated, under the stated 
experimental conditions. The detection limit is expressed as concentration of 
analyte (e.g.: percentage, parts per billion). 
Determination: It is determined by assaying a sufficient no: of aliquots of 
homogenous sample to be able to calculate statistically valid estimates of 
standard deviation or % RSD.  
 
LOD = 10 x Standard deviation 
                           Slope 
            Linearity58, 59 
   It is the ability to elicit test results that are directly, or by a well defined 
mathematical transformation, proportional to concentration of analyte in samples 
which in a given range. If linearity is not attainable, a non-linear model may be 
used, however, the goal is to have a model, whether linear/non-linear that 
describes closely the concentration-response relationship. 
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           System suitability58, 59 
        Tests are based on the concept that the equipment, electronics, 
analytical operation and samples constitute an integral system that can be 
evaluated as such. 
           Chromatographic parameters 
TABLE NO: 27 
 
 PARAMETERS VALUES 
1 Wavelength 254nm 
2 Flow rate 1.2ml/mt 
3 Column C18 
4 Injection volume 20 µl 
 
 
Preparation of Calibration curve 
               For the preparation of calibration curve, aliquots of 1ml, 2ml, 3ml, 
4ml, 5ml were pippeted out and the volume was made up to 100ml with methanol 
to produce concentrations in the range of 10-50µg/ml. Each solution was injected 
and a chromatogram was recorded. The peaks were recorded. Calibration curve 
was constructed by plotting concentration vs. peak area and was recorded in table 
no: 28 and and the chromatogram was shown in chromatogram no: 1 
TABLE NO: 28 
Concentration Peak area 
10 1231.309 
20 2456.657 
30 3730.062 
40 4906.374 
50 6163.697 
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Calibration curve 
 
CHROMATOGRAM NO: 1 
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Assay 
            10 tablets were accurately weighed and ground to fine powder. Powder 
equivalent to 50mg of nitazoxanide was accurately weighed, dissolved and made 
up with methanol. From this 5ml was pippeted and transferred to 100ml standard 
flask and the volume was made up with mobile phase. 20µl of the solution was 
injected and the chromatogram was recorded. In the similar manner 
chromatogram of pure drug as same concentration was also recorded in table no: 
29 and was shown in chromatogram 2, 3, 4, 5, 6 and 7. 
 
 
Calculation 
 
Test absorbance  
Std absorbance
 x 
Wt of std drugሺmgሻ
50
 x 
5 
100
 x 
50 
wt of tablet powder ሺmgሻ
 x Avg wt oftablet ሺmgሻ 
 
 
 
DATA FOR ASSAY OF TABLET 
 
(Label claim: 500mg) 
 
TABLE NO: 29 
 
 
 
  
Sl 
no: 
Brand 
name 
Avgwt 
of tablet
(mg) 
Wt of 
std 
drug 
(mg) 
Avg peak 
area for 
test 
Wt of 
tab 
powder 
(mg) 
Avg 
peak 
area for 
std 
Avg  
content 
(mg) 
 
1 
 
NIZO
NIDE -
500mg 
 
1285.1 
 
50.4 
 
3220.388 
 
68.2 
 
6160.406 
 
496.58 
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CHROMATOGRAM: 2 
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CHROMATOGRAM: 3 
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CHROMATOGRAM: 4 
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CHROMATOGRAM: 5 
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CHROMATOGRAM: 6 
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CHROMATOGRAM: 7 
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System suitability parameters 
 
TABLE NO: 30 
 
 Sl 
no: 
 
      Parameters 
 
      Observed values 
 
    Acceptance  
 criteria 
 
1 
 
No: of theoretical plates 
          (N)                      
 
1917.22 
 
Not less than 2000 
 
2 
 
  Tailing factor (T) 
 
1 
 
≤ 2.0 
 
3 
 
  Linearity                         
 
-- 
 
-- 
 
4 
 
Correlation coefficient 
 
0.9999507 
 
0.9999 
 
5 
 
Limit of Detection 
 
0.0747 
 
 
-- 
 
6 
 
Limit of Quantitation 
 
0.0246 
 
-- 
 
7 
 
% RSD 
 
0.185 
 
-- 
